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Investigating Visual Function and Cortical Structure in Groups with (or at Risk for) Alzheimer’s 
Dementia 
Sana Rehan 
Poor sensory performance is cross-sectionally associated with poorer cognition and 
increases risk for cognitive decline and Alzheimer’s dementia (AD). The purpose of this study 
was to characterize the degree of visual impairment in individuals with (or at risk for) dementia 
and explore the effects of this sensory-cognitive relationship on brain structure.  
Using the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-
ND) dataset, we analyzed vision and imaging data from three diagnostic groups: individuals with 
subjective cognitive decline (SCD; N = 53), mild cognitive impairment (MCI; N = 102), and 
mild AD (N = 45). We characterized used ANCOVAs to determine whether visual performance 
on reading acuity and contrast sensitivity differed as a function of clinical diagnosis. Cortical 
thickness and volume were extracted using FreeSurfer, and hierarchical regression analyses were 
done to determine whether visual performance predicted brain structure (i.e., cortical thickness 
and volume) beyond diagnostic group membership. 
We found that the AD group performed significantly worse on reading acuity and 
contrast sensitivity compared to the SCD and MCI groups, which did not differ from each other. 
Despite our independent findings that visual performance differs across diagnostic groups and 
that group membership predicted cortical structure, our results demonstrate that visual 
performance does not predict cortical structure above and beyond clinical diagnosis. Our 
findings support the hypothesis that atrophy in underlying visual areas and pathways is 
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Investigating Visual Function and Cortical Structure in Groups with (or at Risk for) 
Alzheimer’s Dementia 
Sensory loss and cognitive decline are common age-related conditions that have a 
detrimental effect on functional independence and quality of life. Previous literature identifies 
sensory loss as one factor that increases the risk for cognitive decline and developing 
Alzheimer’s dementia (AD; Livingston et al., 2017) and is associated with reduced physiological 
integrity and degeneration in the aging brain (Albers et al., 2015). The goal of our research was 
to characterize visual function in different clinical populations with (or at risk for) dementia, as 
well as explore the effects of this sensory-cognitive relationship on cortical structure in sensory 
regions. In this thesis, I will review previous research that has examined cross-sectional and 
longitudinal relationships between visual impairment and cognitive decline in healthy and 
clinical populations. Several hypotheses have been suggested to explain this sensory-cognitive 
relationship, such as the common-cause hypothesis (i.e., a third common factor associated with 
aging causes both sensory and cognitive decline) and the sensory deprivation hypothesis (i.e., 
prolonged sensory decline leads to cognitive deterioration through functional and structural 
changes in the brain). Evidence for each hypothesis will be presented to elucidate our rationale 
for investigating the effect of the visual-cognitive relationship on brain structure.   
Introduction to Alzheimer’s Dementia 
AD is an increasingly common age-related neurodegenerative disease with profound 
personal and economic costs. It is classified as a severe level of impairment marked by cognitive 
deficits and deterioration in daily functioning and independence. AD is one of the leading causes 
of death and disability and is expected to affect more than 100 million globally by 2050. In 




564 000 in 2016 to 937 000 by 2031 (Alzheimer Society of Canada, 2016). Moreover, the 
combined healthcare and caregiver costs for AD are expected to rise from $10.4 billion in 2016 
to $16.6 billion by 2031 (Alzheimer Society of Canada, 2016). Given these staggering costs, the 
identification of at-risk individuals and prevention of AD has become a priority worldwide.  
Identification of at-risk or intermediate states in the progression of disease pathology is 
crucial in AD prevention. Early stages of dementia include objective and/or subjective declines 
in cognitive function beyond that associated with typical aging, although these conditions do not 
always convert to future dementia. Mild cognitive impairment (MCI) represents a prodromal 
state of objectively impaired cognitive function that overlaps normal age-related cognitive 
decline and the onset of AD, with the estimated prevalence ranging between 10-20% of 
individuals older than 65 years of age (Petersen, 2011). Compared to AD, there is preservation of 
functional independence in MCI individuals. Although not all MCI individuals progress to 
dementia, the general rate for progression is 10% per year in high-risk clinical populations and 
can be heightened by other factors, such as degree of cognitive impairment at baseline or genetic 
and neuroimaging biomarkers (Petersen, 2011). A preclinical stage to MCI and AD is subjective 
cognitive decline (SCD) in individuals who are clinically healthy, but express concern over a 
self-perceived decline in cognitive function without evidence of objective cognitive impairment 
on standardised cognitive testing or interference in daily functioning (Jessen et al., 2014; Jessen 
et al., 2020). 
Prevalence and Burden of Sensory Loss 




While the most prominent deficits in early cognitive decline and dementia are associated 
with cognitive impairment (e.g., memory loss), sensory deficits (e.g., hearing and vision loss) are 
prevalent in MCI and AD patients (see Albers et al., 2015 for a review). Rapid population aging 
is associated with increased prevalence rates for visual impairment globally. In 2019, the World 
Health Organization (WHO) estimated that out of the 2.2 billion of the world’s population are 
estimated to have a visual impairment. Specifically, an estimated 188 million had mild vision 
impairment (visual acuity worse than 6/12 but 6/18 or better; 217 million had moderate or severe 
vision impairment (visual acuity worse than 6/18 but 3/60 or better), and 36 million people were 
blind (reported visual acuity worse than 3/60; Bourne et al., 2017).  Rates of moderate and severe 
vision impairment are estimated to increase to 237.1 million people in 2020 and 587.6 million 
people in 2050. Rates for blindness are also expected to rapidly increase and project to 38.5 
million by 2020 and 115 million by 2050. 
In the same prevalence study, individuals 50 years or older had the highest burden of 
vision impairment, representing globally 86% of blind individuals, 80% of individuals with 
moderate to severe vision impairment, and 74% of individuals with mild vision impairment 
(Bourne et al., 2017). These impairments were largely due to unaddressed refractive error and 
cataracts; however, other important causes of vision loss in aging populations include eye-related 
diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma 
(Pascoloni et al., 2011).   
In Canada, vision loss also presents as a widespread problem. As reported in the Cost of 
Vision Loss Summary Report in 2009, 817 000 Canadians are currently living with some form of 
vision loss, leading to national healthcare costs of over $30 billion per year (Cruess, Gordon, 




25 years, with the number of cases with vision loss doubling after 40 years of age and tripling 
after 75 years of age. In a recent study using data from the Canadian Longitudinal Study on 
Aging, which assessed data from approximately 30 000 Canadians 45-85 years of age, mild and 
moderate vision loss (in terms of acuity) was prevalent among 19.8% and 2.4% of males and 
23.9% and 2.6% of females, respectively, with vision loss increasing steadily with age (Mick et 
al., 2020).  
Prevalence of Visual Impairment in Populations with AD 
Along with advancing age, memory problems have been identified as one factor 
associated with higher odds of visual impairment (Aljied, Aubin, Buhrmann, Sabeti, & Freeman, 
2018).  In a large Canadian database of 30 097 people between 45-85 years old, individuals with 
visual impairment also reported problems with memory with 10% of this group reporting having 
previously been diagnosed with dementia or AD (Aljied et al., 2018). Similarly, it has been 
demonstrated that older individuals often have both cognitive and visual impairments. For 
example, visual impairment was reported in 50 (37.3%) of 150 residents with a diagnosis of 
dementia residing in a long-term care facility (Chriqui, Law, Kergoat, Leclerc, & Kergoat, 
2017). In another study, the prevalence of visual impairment (measured by visual acuity worse 
than 6/12) was 32.5% in 708 patients with dementia aged 60-89 years (Bowen et al., 2016). 
Therefore, the well-established association between cognition and visual function, as well as the 
prevalence of vision deficits in dementia populations, compels further examination of the role of 
sensory loss on cognitive outcomes.  
Functional Burden of Visual Impairment  
Visual impairment has a profound impact on the preservation of daily functioning and 




activities of living and report greater social dependence and medication errors (Gordon, Cruess, 
Bellan, Mitchell, & Pezzullo, 2011). Visual impairment is also associated with twice the risk of 
falls (Harwood, 2001; Kulmala et al., 2009) and mortality (McCarty et al., 2001), increased risk 
for frailty (Swenor, Lee, Tian, Varadaraj, & Bandeen-Roche, 2020), as well as four times the risk 
for serious hip fractures and early admission to nursing homes (Vu, Keeffe, McCarty & Taylor, 
2005). Specifically, individuals with age-related maculopathy or glaucoma have demonstrated 
mobility difficulties, especially with driving and balance (Scilley et al 2002; Popescu et al 2011). 
Finally, Whitson et al (2007) found that participants with comorbid visual and cognitive 
impairment were at a greater risk of disability in activities of daily living compared to 
individuals with just visual or cognitive impairment alone. 
Other consequences of visual impairment include social isolation and reduced 
communication and participation in leisure activities, an increase in depressive symptoms, as 
well as poor quality of life (Hassell, Lamoureux, & Keeffe, 2006; Han, Lee, Jung, & Park, 2018). 
Regardless of the degree of vision loss, individuals with vision complaints report poor quality of 
life with concern about worsening eyesight and coping with everyday life (Hassell et al., 2006). 
Moreover, limited mobility and household activity due to poor vision can negatively impact 
overall subjective well-being (Xiang et al., 2020). Compared to healthy controls, patients with 
AMD or glaucoma participated in fewer cognitive activities per month and were at a higher risk 
of disability if they had coexisting visual and cognitive impairment, with each eye-related 
condition contributing additively to the risk (Varin et al., 2017). Together, these studies 
demonstrate the impact of poor vision on day-to-day functioning and overall quality of life.  
Sensory Function and Cognitive Decline 




Early studies have reported that sensory functioning can be a strong predictor of 
individual differences in cognitive functioning in late life (Lindenberger & Baltes, 1994). More 
specifically, visual and auditory acuity predicted a significant amount of age-related variance in 
performance on cognitive tests. Beyond changes in cognitive functioning, sensory impairment 
has been linked with an increased risk for dementia (Brenowitz, Kaup, Lin, & Yaffe, 2019; Luo 
et al., 2018). This sensory-cognitive relationship has been supported by recent longitudinal 
studies that have found that changes in hearing (Gates, Anderson, Feeney, McCurry, & Larson, 
2008; Lin et al., 2011) and vision (Zheng et al., 2018, Fischer et al., 2016) may precede a 
diagnosis of AD and can serve as risk factors for cognitive impairment with advancing age.  
There is well-established literature on the relationship between hearing and cognition. 
Hearing loss (HL) is one of the most prevalent sensory deficits in older adults, and multiple 
longitudinal studies have identified a relationship between age-related hearing loss or central 
auditory function and the risk of dementia five to 10 years later in individuals who were 
cognitively normal or had mild memory impairment without dementia at baseline (Gates, Beiser, 
Rees, D’Agostino, & Wolf, 2002; Gates, Anderson, McCurry, Feenery, & Larson, 2011). 
Moreover, auditory function has been associated with performance on cognitive tasks. In one 
prospective study with cognitively healthy participants from the Baltimore Longitudinal Study of 
Aging, hearing loss was independently associated with non-verbal and verbal measures of 
cognition over six years (Lin et al., 2011). These findings have profound implications for 
determining the role of HL in cognitive decline and the development of AD, moreover; the HL-
cognitive link has provided a greater understanding of the larger relationship between sensory 




However, the link between sensory impairment and cognitive function is not unique to 
just one sensory system (i.e., limited to hearing, Albers et al., 2015). There is also a growing 
body of empirical evidence supporting associations between visual function and cognitive 
impairment (Lin et al., 2004; Anstey, Luszcz, & Sanchez, 2001; Spierer, Fischer, Barak & 
Belkin, 2016; Chen, Bhattacharya, & Pershing, 2017; Reyes-Ortiz et al., 2005; Swenor et al., 
2018; Zheng et al., 2018; Mine et al., 2016). In one longitudinal study that investigated the 
association between sensory impairment (hearing, sensory, or dual) and cognitive decline in 
women aged 69 years or older, Lin et al. (2004) found that combined hearing and vision 
impairment and vision impairment alone were at higher risk for cognitive decline relative to 
hearing impairment alone. Hearing impairment was defined as the inability to hear a tone of 40 
dB or greater at 2,000 Hz frequency in the better ear, and visual impairment was defined as 
having corrected binocular vision worse than 20/40. Cognitive decline was measured by the 
amount of change in scores on a modified version of the Mini-Mental State Examination (3MS) 
from baseline to follow-up (4.4 years) that exceeded the average change in scores by at least one 
standard deviation. Lin et al (2004) found that combined visual and hearing impairment had the 
greatest risk for cognitive (odds ratio (OR): 2.19) and functional (OR = 1.87) decline, followed 
by vision impairment alone (OR for cognitive decline = 1.78, functional decline = 1.79) and 
hearing impairment alone (OR for cognitive decline = 1.38, functional decline = 1.10). In 
another study with a similar methodological design and cognitively healthy persons over the age 
of 70, Anstey et al. (2001) found that a two-year decline in visual acuity, but not hearing, had a 
significant effect on visual memory decline. Together, these studies demonstrate a link between 
visual impairment and cognitive decline that is independent of having another sensory 




The Vision-Cognition Relationship among Persons with no Eye Disease who are Cognitively 
Normal at Baseline 
 Associations between Visual Function and Cognitive Performance in Cognitively 
and Visually Healthy Individuals. Previous findings support a vision-cognition relationship, in 
that poor performance on psychophysical measures of vision (e.g., impairments in visual acuity, 
contrast sensitivity, color vision, motor perception, or visuospatial processing) has been cross-
sectionally associated with poor cognition in healthy older adults (see Albers et al., 2015; Tzekov 
& Mullan, 2014 for a review). In normative populations that are cognitively healthy, multiple 
studies have demonstrated associations between poorer performance on visual tests with poorer 
cognitive function. For example, better visual function (as measured by visual acuity) was 
associated with better cognitive performance on the Mini-Mental State Exam (MMSE; Spierer et 
al., 2016; Mine et al., 2016). In fact, Mine et al. (2016) found that individuals with mild visual 
impairment had 2.4 times odds (cross-sectionally) of having cognitive impairment compared to 
individuals without visual impairment, controlling for age, sex, and education. In another study, 
Chen et al. (2017) found that both distance and self-reported visual impairment (as measured by 
visual acuity) was associated with lower scores on other measures of cognitive function (i.e., the 
Digit Symbol Substitution test) in healthy respondents aged 60 years or older even after 
accounting for demographics and socio-economic status.   
Longitudinal Associations between Visual Function and Risk for Cognitive Decline. 
Poor performance on visual measures at baseline have also been associated longitudinally with 
poor global cognition (e.g., MMSE scores) or cognitive decline at follow-up assessments (Reyes-
Ortiz et al., 2005; Lin et al., 2004; Swenor et al., 2018; Zheng et al., 2018; but see Hong, 




al. (2005) found that near vision impairment at baseline was associated with cognitive decline 
(i.e., a drop in MMSE performance) at a 2-year follow-up assessment in Mexican Americans 
aged 65 years or older. These findings have been supported by other studies that assessed 
cognitive decline as a function of change in global cognition scores using the MMSE (Lin et al., 
2004; Swenor et al., 2018; Zheng et al., 2018). For example, Zheng et al. (2018) measured visual 
acuity and global cognition (MMSE) in 2520 older adults registered in the Salisbury Eye 
Evaluation Study at baseline and four different time points. Results from their study 
demonstrated that visual impairment was associated with declining cognitive function both 
cross-sectionally and longitudinally over time, with worsening vision having a stronger 
association with declining cognition. Moreover, individuals with poor visual acuity, CS, and 
stereo acuity at baseline presented greater decline on cognitive scores (MMSE) over 9 years, 
with the hazard ratio for incident cognitive impairment being the highest for the group with poor 
visual acuity at baseline (Swenor et al., 2018). On other cognitive tasks besides the MMSE, 
Anstey et al. (2001) found that performance decline in visual acuity was associated with visual 
memory decline (but not with processing speed or verbal ability) over two years in the 
Longitudinal Study of Aging. Moreover, Valentijn et al. (2005) found that a change in visual 
acuity was associated with a change in scores on some tasks measuring auditory memory, 
processing speed, and executive function. This particular finding supports an association 
between sensory acuity and cognitive performance across multiple domains, both cross-
sectionally and longitudinally. Overall, this literature provides substantive evidence that worse 
vision in older adults may be adversely associated with cognitive function over time.    
 Cross-sectional and Longitudinal Associations between Visual Function and Risk 




sectionally and longitudinally at follow-up assessments. In cross-sectional studies, for example, 
Uhlmann et al. (1991) found that the risk of dementia associated with near-vision impairment 
remained significant, even after adjusting for other risk factors such as family history of 
dementia, depression, medication, and hearing impairment. Moreover, Uhlmann et al. (1991) 
found that both near- and far-vision impairment (visual acuity) were significantly associated with 
poorer cognitive function on the MMSE, even after excluding vision-dependent items on the 
MMSE. Despite the association between visual impairment and the risk and clinical severity of 
dementia, their findings did not support an increased relative risk for cognitive dysfunction with 
greater visual impairment (i.e., a dose-response relationship). Low visual acuity has also been 
identified as one risk factor for MCI in individuals aged 70-90 years (Sachdev et al., 2012).  
The link between visual impairment and risk for dementia has also been established 
longitudinally in multiple studies (Fischer et al., 2016; Davies-Kershaw et al., 2018; Ward et al., 
2018; Naël et al., 2019; Elyashiv, Shabtai, & Belkin, 2014; Rogers & Langa, 2010; Hajek et al., 
2016). For example, Davies-Kershaw et al (2018) found that healthy individuals aged 50-69 who 
had moderate and severe visual impairment at baseline were 2 and 4 times as likely, respectively, 
to have dementia at a 10-year follow-up compared to those who reported normal vision at 
baseline. When age-related eye diseases were entered into the hazards model, individuals in the 
same age group were still at greater risk of developing dementia, although this was no longer 
statistically significant. Rogers and Langa (2010) also established the link between untreated 
poor vision and risk for cognitive decline and AD, more specifically, participants with excellent 
vision at baseline presented a 63% reduced risk of dementia over 8.5 years on average, whereas 
patients with poor vision at baseline (who also did not visit an ophthalmologist) had a nine-fold 




similar study with a wider age range (individuals aged 53-102 years), poorer visual acuity at 
baseline was correlated with a higher risk for dementia and worse global cognitive scores over 
10 years (Elyashiv et al., 2014). However, Elyashiv et al. (2014) did not report the aetiology of 
visual impairment among their participants. Finally, Ward et al. (2018) demonstrated that poor 
contrast sensitivity at baseline not only predicted reduced cognitive performance, but also 
development of MCI or dementia over a decade later in older women. Specifically, the risk for 
dementia doubled in women who performed in the lowest quartile for contrast sensitivity at 
baseline. Moreover, the association between contrast sensitivity and MCI/AD remained even 
after excluding women with base- line self-reported glaucoma or AMD. Thus far, these results 
support a directional pattern of the relationship between visual impairment and cognitive decline, 
in that poor visual function at baseline can predict development of cognitive decline and 
dementia over time.  
In another longitudinal study with multiple follow-up assessments, Fischer et al. (2016) 
found that visual impairment was independently associated with risk of cognitive impairment (as 
indicated by a <24/30 score on the MMSE or history of dementia). However, it is important to 
note that despite this independent association between visual function and cognitive impairment, 
81% of all individuals with visual impairment at baseline did not develop cognitive impairment 
at follow-up assessments. Therefore, although we can hypothesize that individuals with AD may 
present with and have a history of mild vision deficits or visual impairment, it may not always be 




The Vision-Cognition Relationship among Persons with Eye Disease who are Cognitively 
Normal at Baseline 
Diagnosed visual impairment and eye-related diseases have likewise been shown to be 
associated with cognitive function. For example, Jefferis et al. (2012) found a relationship 
between visual impairment and poor MMSE scores with older adults aged 85 years or older who 
were registered as sight impaired by a consultant ophthalmologist. More specifically, individuals 
with registered sight impairment scored worse compared to healthy controls on MMSE items 
that both did and did not require vision, suggesting that poor vision may impact cognition in a 
domain-general manner (i.e., on both auditory and visual tasks). In multiple studies measuring 
visual impairment as a function of an AMD diagnosis (Clemons, Rankin, & McBee, 2006; Pham, 
Kifley, Mitchell, & Wang, 2006), individuals with AMD were more likely to demonstrate lower 
global cognition scores on the MMSE compared to healthy controls, even after excluding visual 
items from the MMSE. Among other cognitive functions, visuospatial function, verbal memory, 
and visual memory were impaired in AMD compared to healthy controls (Woo et al., 2012). 
Notably, Woo et al. (2012) found poorer cognitive function in AMD patients compared to 
healthy controls even after adjusting for age and visual acuity, suggesting that cognitive 
impairment in AMD patients is not exclusively due to poor vision and may be attributable to 
neurodegenerative changes in the brain. Moreover, Zhu et al. (2019) noted that participants with 
any degree of AMD had a higher prevalence of subjective cognitive complaints relative to 
participants without AMD.  
Patients with other eye-related diseases such as cataracts, glaucoma, and diabetic 
retinopathy have also demonstrated lower global cognitive scores (e.g., on the MMSE; Harrabi et 




encoding (e.g., Digit Span, Logical Memory; Varin et al., 2019) compared to healthy controls 
with normal vision. These findings indicate that cognitive impairment in populations with visual 
deficits or eye-related diseases extends across multiple cognitive domains and is not exclusive to 
visuospatial function or visual memory. Moreover, these findings further support the visual-
cognitive relationship, in that they elucidate an established link between cognitive decline and 
clinical visual impairment (i.e., diagnosed or registered visual deficits) over and above poor 
performance on psychophysical measures of visual function. Finally, the connection between 
eye-related diseases and cognitive decline compels further investigation on associations and 
shared mechanisms between eye-related diseases and development of dementia.  
The Vision-Cognition Relationship among Persons with no Eye Disease who are Cognitively 
Impaired at Baseline 
Cross-sectional Associations between Visual Function and Cognitive Decline. Cross-
sectional findings have demonstrated that clinical populations with MCI and AD demonstrate 
poorer performance on visual measures compared to healthy older adults. For example, AD 
individuals demonstrate worse performance on measures of psychophysical visual function 
compared to healthy controls, such as visual acuity (Uhlmann, Larson, Koepsell, Rees, & 
Duckert, 1991), contrast sensitivity (Hutton, Morris, Elias, & Poston, 1993; Rizzo, Anderson, 
Dawson, & Nawrot, 2000; Nissen et al., 1985), spatial orientation (Henderson, Mack, & 
Williams, 1989), figure copying, colour vision/discrimination, and stereopsis (Cronin-Golomb, 
Rizzo, Corkin, & Growdon, 1991a; Kiyosawa et al., 1989; Pache et al., 2003; Salamone et al., 
2009), general perceptual organization and visuospatial perception (Kurylo, Corkins, & 
Growdon, 1994; Mandal, Joshi, & Saharan, 2012), and motion and depth perception (Mendez & 




in near- and far-visual acuity in AD cases compared to healthy controls. They also found a 
significant correlation between the degree of visual impairment and severity of cognitive 
dysfunction in AD patients, even after adjusting for family history of dementia, depression, drug 
use, and hearing impairment.  
Other studies have also been conducted comparing visual function across clinical groups 
with varying degrees of AD pathology. More specifically, Marquie et al. (2019) found that 
individuals with dementia demonstrated worse visual acuity compared to SCD and MCI groups 
when controlling for age, sex, and education. In fact, patients with dementia were 3.4 and 1.6 
times more likely to present poorer visual acuity compared to the SCD and MCI groups, 
respectively. Additionally, there were no group differences in previously diagnosed eye-related 
disorders (e.g., open-angle glaucoma, age-related macular degeneration) that are the leading 
causes of vision loss. In another study comparing across diagnostic groups, both MCI and AD 
groups demonstrated greater contrast sensitivity deficits compared to individuals with cognitive 
complaints or healthy controls, while the group with cognitive complaints performed 
intermediately between the MCI cognitively healthy controls (Risacher et al., 2013). Risacher et 
al. (2013) also demonstrated a significant association between performance on contrast 
sensitivity and on cognitive tasks of general cognition (MMSE) and auditory memory. Overall, 
these studies support the vision-cognition relationship in demonstrating that visual deficits are a 
feature of AD and AD-related changes; moreover, review of this literature suggests that AD (and 
possibly MCI) individuals are likely to perform worse on various visual domains compared to 




Mechanisms Underlying the Sensory-Cognitive Relationship 
Despite growing evidence for a link between visual impairment and cognition, the 
underlying mechanisms are still unclear. Several theories have been suggested to explain the 
relationship between sensory and cognitive decline, which often overlap and interrelate in 
complex ways. However, only a few hypotheses have been explored in studies assessing the 
specific link between vision and cognition.  
One theory is the common-cause hypothesis, which suggests that a common factor 
associated with aging causes both sensory and cognitive decline through widespread neural 
degeneration, such as the presence of eye-related diseases (Lindenberger & Baltes, 1994; Baltes 
& Lindenberger, 1997). Another theory is of the social isolation hypothesis, which posits that 
social variables mediate the sensory-cognitive link, such that visual impairment negatively 
influences cognitive function through limiting social participation and communication (Clemons 
et al., 2006; Verghese et al., 2006; Zheng et al., 2018). For example, poor vision can reduce 
ability to participate in mental and physical activities that promote brain stimulation and well-
being, which can be a risk factor for cognitive decline. Another hypothesis that has been 
presented in vision-cognition research is the information degradation hypothesis, which is that 
degraded perceptual inputs can lead to both errors in basic perceptual processing and higher-
order cognitive processes (Lindenberger & Baltes, 1994; Monge & Madden, 2016; Valentijn et 
al., 2005). This theory has been supported by Monge & Madden (2016), who found that 
manipulation of the quality of visual input signals could affect performance on cognitive tasks. 
Finally, the sensory deprivation hypothesis posits that prolonged sensory decline gradually leads 




Baltes, 1994). However, the effect of the relationship between visual impairment and cognitive 
decline on brain structure remains largely understudied. 
Evidence for the Common-Cause Hypothesis 
In support of the common-cause hypothesis, individuals with AD often have concomitant 
diagnoses with age-related eye diseases (Albers et al., 2015). Moreover, previous findings 
suggest a bidirectional relationship between development of AD and eye-related disease, such 
that AD individuals are at a higher risk for developing age-related eye diseases and individuals 
with eye-related diseases also present cognitive impairment and risk for AD. Finally, besides the 
fact that age is a principal risk factor for both AD and eye-related diseases, these conditions often 
share similar neuropathological pathways (see Albers et al., 2015; Ikram, Cheung, Wong, & 
Chen, 2012; Kusne, Wolf, Townley, Conway, & Peyman, 2017 for a review). Given this overlap, 
the following paragraphs will discuss similarities in clinical and neuropathological presentations 
in common ophthalmic conditions and AD.  
Clinical Associations between AD and AMD 
In a comprehensive meta-analysis of 21 studies investigating the association between AD 
and AMD, Rong et al. (2019) found that patients with dementia or AD were at risk for AMD. 
This meta-analysis emphasized the association between dementia/AD and AMD across multiple 
cross-sectional, case-control and cohort studies. Moreover, patients with AMD had poorer 
cognitive functions when compared with healthy controls with no visual impairment; however, 
this was mostly for studies that adopted vision-dependent cognitive function tests. In the opposite 
direction (e.g., development of AD following diagnosis of AMD), a retrospective cohort study 
by Choi, Jahng, Park, and Jee (2019) demonstrated that compared to non-AMD patients, AMD 




lifestyle behaviours. Klaver et al. (1999) similarly found an increased risk of incident AD over 
two years if subjects had AMD at baseline. Within AMD populations, Woo et al., (2012) also 
found that AMD patients with poor visual acuity (<20/100) had a six-fold higher risk for 
developing MCI compared to other AMD subjects with good or moderate visual acuity 
(>20/100). However, it is also important to consider that other studies have found no elevated 
risk of developing AD following AMD (Keenan, Goldacre, Goldacre, & Hyman, 2014) and no 
association between AD and AMD (Williams et al., 2015). 
Shared Features between AD and AMD 
A shared prominent neuropathologic feature between AD and AMD are extracellular 
amyloid deposits, which have been detected in early AMD drusen and AD senile plaques (see 
Ohno-Matsui, 2011 for a review on parallel findings between AD and AMD). In fact, amyloid 
proteins have been implicated in initiating the inflammatory cascade that leads to drusen 
formation and atrophy in the retina, which are present in both AD and AMD individuals 
(Johnson et al., 2002). Moreover, neurofibrillary tangles are a common shared condition in both 
AD and AMD. Although plaques and tangles can also be present in many cognitively healthy 
individuals, amyloid beta plaques and neurofibrillary tangles have been found at different levels 
of the visual system in AD persons, ranging from subcortical areas such as the lateral geniculate 
nucleus (i.e., the relay centre that projects information from retinal ganglion cells to higher-order 
cortical areas) and cortical regions associated with visual function (e.g., primary and associative 
visual cortices; Albers et al., 2015; Ikram et al., 2012). Leuba and Sani (1995) also demonstrated 
that neuropathology (i.e., neuritic plaques and tangles) in the visual association cortex occurred 
later in disease progression, demonstrating that atrophy in visual-related cortical areas may only 




(2006) presented that all subjects with mild cognitive or suspected AD had dense tangles and 
neuritic plaques in the visual association cortex; therefore, they suggest that neuropathology may 
occur early in vision-processing brain regions prior to their occurrence in the hippocampus. 
Therefore, similar pathology between AD and AMD at various levels of the visual pathway and 
related structures may explain poor vision function in AD.  
Clinical Associations between AD and Glaucoma 
Previous findings demonstrate an increased incidence rate of glaucoma in patients who 
have AD (Bayer & Ferrari, 2002; Tamura et al., 2006). In fact, the occurrence rate of glaucoma 
in 112 AD patients was 25.9% compared to 5.2% in cognitively healthy controls (Bayer & 
Ferrari, 2002). In one retrospective population-based cohort study Lin, Hazzard, & Blazer (2016) 
established a higher incidence rate of AD among patients with primary open-angle glaucoma 
(2.85) compared to controls without primary open-angle glaucoma (1.98). Moreover, Lin et al. 
(2016) found that a diagnosis of primary open-angle glaucoma predicted development of AD in 
elderly patients aged 60 years or older. In Taiwanese older adults, glaucoma is associated with 
1.5-fold increased odds for developing AD (Lai, Lin, & Liao, 2017). In contrast to these studies, 
Kessing, Lopez, Andersen, & Kessing (2007) found no increased risk for developing AD in 
patients with glaucoma.  
Shared Features between AD and Glaucoma 
Beyond age, AD shares similar retinal features with glaucoma, such as thinning of the 
retinal nerve fiber layer (RNFL), a loss of retinal ganglion cells, and optic nerve degeneration 
(Valenti, 2011; Hinton, Sadun, Blanks, & Miller, 1986; Bambo et al., 2014; Lu et al., 2010; 
Kirbas, Turkyilmaz, Anlar, Tufekci, & Durmus, 2013). It has been hypothesized that both 




cells, which may progressively lead to thinning of the RNFL and optic nerve (Valenti, 2011). 
Given these similarities, glaucoma has been identified as an early (non-memory) manifestation 
of AD in older people (Lai et al., 2017). This is because retinal abnormalities and pathology that 
are common in patients with glaucoma are observed early in AD, with noticeable patterns in 
RNFL loss, narrow veins and decreased blood flow in retinal veins (Berisha, Feke, Trempe, 
McMeel, & Schepens, 2007; Blanks, Hinton, Sadun, & Miller, 1989; Blanks, Torigoe, Hinton, & 
Blanks, 1996a; Blanks et al., 1996b). In a recent meta-analysis of 11 imaging studies (optical 
coherence tomography), AD patients had a significant reduction in mean RNFL and in all four 
retinal quadrants around the macula (Coppola et al., 2015). Compared to age-matched healthy 
controls, retinas of AD patients present widespread axonal degeneration in the optic nerves and a 
profound reduction in the number of retinal ganglion cells (Hinton et al., 1986). Abnormal RNFL 
thickness have also been observed in MCI groups and in early AD patients with normal visual 
function (Kesler, Vakhapova, Korczyn, Naftaliev, & Neudorfer, 2011; Paquet et al., 2007; Lu et 
al., 2010). These studies indicate that pathological changes in the retina occur early in AD 
progression and may have diagnostic relevance in early identification and prevention. It is also 
important to note that RNFL thickness in AD is linked to reductions in retinal ganglion cells and 
optic nerve axons, which are critical in transferring visual information to the brain (Kusne et al., 
2017). Therefore, there is strong evidence for prominent involvement of the retina and related 
structures in AD, which may explain poor perceptual processing and visual function in AD. 
Evidence for the Sensory Deprivation Hypothesis 
In addition to ocular and vascular abnormalities, there is evidence of functional and 
structural changes in visual-processing brain regions as a result of normal aging. Previous 




(Jorge, Canário, Quental, Bernardes, & Castelo-Branco, 2020; Salat et al., 2004; Fjell et al., 
2009; McGinnis, Brickhouse, Pascual, & Dickerson, 2011; but also see Thambisetty, 2008; 
Lemaitre, Goldman, & Sambataro, 2012 for evidence that does not support age-related changes 
in V1). A more recent study by Griffis, Burge, and Visscher (2016) further presented that age-
dependent cortical thickness occurred specifically in the anterior portions of V1 that correspond 
with peripheral vision; therefore, age-related changes in cortical thickness may be unique to 
specific regions and not all aspects of visual function may be affected in normal aging. 
Supporting this, the authors hypothesize that cortical changes in areas of peripheral vision may 
mirror normal, age-related functional decline in complex visual tasks requiring peripheral vision. 
Spear (1993) has similarly hypothesized that age-related neural changes (e.g., damage to the 
parvocellular pathway) are associated with a functional reduction in visual acuity. Therefore, 
age-related structural changes in brain areas involved in sensory processing (i.e., vision-related 
areas) may potentially contribute to decline in visual function. 
Although sparse, the link between visual function and cortical changes in clinical 
populations with visual impairment has also been investigated in functional and structural studies 
of the brain. For example, there is EEG evidence of disrupted communication within brain visual 
networks and damage to the visual pathway in partially blind patients (Bola, Gall, & Sabel, 
2015). There is also evidence of decline in functional activity in the visual cortex in patients with 
early glaucoma, however; this reduction in activity may also be influenced by structural 
degeneration in the visual cortex (Murphy et al., 2016). With their findings, Murphy et al. (2016) 
demonstrate that functional abnormalities in the brain may be present before substantial vision 




Multiple studies have found reduced cortical thickness and volume in regions associated 
with visual processing in groups with profound visual impairment (e.g., patients with glaucoma, 
AMD, central vision loss, visual field deficits, and monocular blindness) compared to healthy 
controls (Burge et al., 2016; Boucard et al., 2009; Plank et al., 2011; Chen et al., 2013; Prins, 
Jansonius, & Cornelissen, 2017; Hernowo et al., 2014). For example, there are findings on 
reduced thickness and gray matter volume in the primary visual cortex and occipital cortices in 
patients with AMD and glaucoma compared to healthy controls (Burge et al., 2016; Boucard et 
al., 2009). Volumetric reductions in the optic nerves, the chiasm, the lateral geniculate bodies, 
the primary visual cortex have also been found in patients with AMD (Hernowo et al., 2014). 
Finally, Lou et al. (2013) found that improved visual input following cataract surgery led to an 
increase in gray matter volume in visual association areas, indicative of cortical plasticity and 
restoration of impaired vision in the visual cortex. Although these studies do not investigate 
cognitive decline, these findings may be interpreted using the sensory deprivation hypothesis, in 
that poor visual input can lead to long-term changes in visual pathways and related structural 
areas. More broadly, these findings provide first insights on the relationship between visual 
impairment and structural decline and pinpoint which specific brain regions may be implicated 
with visual impairment.  
 Finally, the impact of the vision-cognition relationship on brain structure and the 
interaction between sensory loss, cognitive decline, and brain integrity has only been explored in 
a handful of studies. Early studies by Cronin-Golomb et al. (1991a) and Rizzo et al. (2000) 
attributed poor performance on visual measures in AD patients to involvement of the primary 
visual and association cortex. In a study with MCI and AD participants, Nishioka, Poh, and Sun 




and tracts as a result of a disrupted visual pathway between the eye and the brain. Finally, in ten 
patients with posterior cortical atrophy, referred to as the visual variant of AD, there was loss of 
both white and gray matter volume in the occipital lobe (Millington et al., 2017). While these 
findings with various methodologies and populations hint at a possible visual-cognitive-brain 
relationship, there is not enough literature to form and establish any strong conclusions on the 
impact of combined sensory-cognitive issues on cortical changes in thickness and volume.  
Rationale 
As evidenced, it remains largely unknown what the effects of the sensory-cognitive 
relationship are on brain structure. Second, while there is some previous research on the 
relationship between visual impairment and structural atrophy in the brain, these studies do not 
investigate the role of cognition in the sensory-brain relationship. Therefore, the purpose of our 
study was to target the interactive sensory-cognitive-brain relationship by 1) characterizing 
visual impairment in older adults with (or at risk for) dementia and 2) investigating the role of 
this sensory-cognitive relationship on brain structure.  
Objectives and Hypotheses 
In the current study, we analyzed data from the Comprehensive Assessment of 
Neurodegeneration and Dementia (COMPASS-ND) to assess three diagnostic groups: SCD (N = 
53), MCI (N = 102), and mild AD (N = 45). The COMPASS-ND dataset is the clinical study of 
the Canadian Consortium on Neurodegeneration in Aging (CCNA), a national initiative aimed 
towards understanding neurodegenerative diseases, working towards prevention, and improving 
quality of life for individuals living with dementia (Chertkow et al., 2019). The COMPASS-ND 
study aims to identify clinical, experimental, genetic, and imaging markers for a wide range of 





Our first objective was to characterize the degree and frequency of visual impairment in a 
large Canadian sample of older adults with (or at risk for) dementia. Measures of reading acuity 
(ability to discern sentences at a given distance) and contrast sensitivity (ability to distinguish an 
object from its background) were used to assess visual functioning in both eyes. Comparisons 
between diagnostic groups using ANOVAs were then calculated to investigate whether 
performance on visual measures differed as a function of clinical diagnosis, controlling for age, 
sex, and education. We also examined whether the sensory-cognitive relationship was 
confounded by prevalence of eye-related diseases across all three diagnostic groups. Based on 
shared neuropathological mechanisms between AD and age-related eye diseases, as well as the 
cross-sectional and longitudinal findings linking visual impairment with cognitive decline and 
dementia, we hypothesized that visual function would differ across diagnostic groups (i.e., the 
AD group will likely have poorer vision compared to the other preclinical groups), over and 
above age.   
Second Objective  
Our second objective was to assess the interaction between visual function, diagnostic 
group membership, and cortical structure. We used T1-weighted MRI images from the 
COMPASS-ND dataset and FreeSurfer to extract cortical thickness and volume from brain 
regions of interest associated with visual processing (controlling for age, sex, education, and total 
intracranial volume).  
Nine ROIs were selected bilaterally based on anatomical location and involvement in 
visual perception and processing: the calcarine sulcus, the cuneus gyrus, occipital pole, middle 




occipital sulcus, superior occipital gyrus, and the inferior occipital sulcus, and the anterior 
occipital sulcus (close to occipito-temporal junction, but connected with parieto-occipital sulcus 
and calcarine fissure). First, our ROIs were based on their involvement in processing reading 
acuity and contrast sensitivity and further supported by the cortical anatomy of the visual 
pathway. Although the we used a more complex measure of high-level reading acuity, basic 
grating acuity has been associated with low-level perception in the primary visual cortex 
(synonymous with V1; Duncan & Boynton, 2003). Contrast sensitivity is also processed in low-
level regions like V1, along with V2, V3, and V5, as well as higher-order processing areas like 
the lateral occipital complex (Avidan et al., 2002). Given the role of the primary visual cortex in 
processing both acuity and contrast sensitivity (i.e., our measures of visual function), we selected 
ROIs that occupy the primary visual cortex, including the calcarine region and the medial surface 
of the occipital lobe, which extends to both the parietal-occipital sulcus and the occipital pole 
(Wichmann & Müller-Forell, 2004). Moreover, as secondary visual cortices are also implicated 
in processing reading acuity and contrast sensitivity, we included regions that surround or are 
connected to the primary visual cortex (e.g., the cuneus, the superior occipital gyrus, the inferior 
occipital gyrus, and the anterior occipital sulcus). 
Second, ROIs were based on previous publications that have used similar region-of-
interest analysis methods and selected visual-based regions to assess cortical thickness and 
volume in individuals with severe visual impairments or blindness (Burge et al., 2016; Boucard 
et al., 2009; Plank et al., 2011; Prins et al., 2011; Hernowo et al., 2014). Common ROIs selected 
by these studies and ours include the calcarine sulcus (and surrounding regions including the 
anterior and posterior banks), the occipital pole, the parieto-occipital sulcus, superior occipital 




posterior regions (e.g., occipital lobe) and anterior regions (e.g., parieto-occipital sulcus) given 
their approximate location and closeness to the superior and inferior banks of the calcarine sulcus 
(i.e., V1).  
 Hierarchical regression analyses were done to determine whether visual function (i.e., 
performance on vision measures) predicted brain structure (i.e., cortical thickness and volume) 
beyond diagnostic group membership. For this objective, although we predicted that group 
membership would alone explain a large portion of variance in cortical structure, we 
hypothesized that worse performance on reading acuity and contrast sensitivity would 
additionally predict reduced cortical thickness and volume based on previous results on strong 
relationships between visual deficits and cortical atrophy in vision-related brain areas. Support of 
these hypotheses may provide novel evidence for the sensory deprivation hypothesis in older 







The first and second waves of COMPASS-ND data were used to assess sensory and 
neuroimaging data from 200 older adults (SCD N = 53, MCI N = 102, AD N = 45). General 
inclusion criteria for participants included sufficient proficiency in English or French to undergo 
self-report and neuropsychological assessment, geographical accessibility to the study site, and 
the presence of a study partner who interacted with the participant weekly and could participate 
if required. Participants also had to be younger than 85 years and have demonstrated subjective 
or objective cognitive impairment.  
General exclusion criteria included: participants with other significant known chronic 
brain diseases unrelated to AD or Parkinson’s disease (e.g., moderate-severe chronic static 
leukoencephalopathy with previous traumatic injury), multiple sclerosis, a serious developmental 
handicap, malignant tumors, and other rarer brain illnesses; participants with on-going alcohol or 
drug abuse, participants without study partners, participants without sufficient proficiency in 
English or French, individuals unable to undergo MRI scanning, and severely impaired 
participants with a score of  < 13 in the Montréal Cognitive Assessment (MoCA) (Nasreddine et 
al., 2005) or with a symptomatic stroke within the previous year were excluded (Chertkow et al., 
2019). The COMPASS-ND study was approved by the Jewish General Research Ethics Board. 
Written informed consent was obtained from all participants.  
From the first and second data releases (total N = 409) of the COMPASS-ND data, 208 
participants were identified that satisfied the criteria for SCD (N = 55), MCI (N = 105), and AD 
(N = 48) following the clinical visit. Eight participants were excluded in total. Five participants 
were excluded due to missing MRI data or clinical data, one participant was an outlier based on 




were outliers based on performance on visual measure, leaving a final sample of 53 SCD 
participants, 102 MCI participants, and 45 AD participants.  
SCD Criteria 
Participants who were diagnosed with SCD were selected based on the following criteria: 
1) self-experienced persistent decline in cognitive capacities in comparison with a previously 
normal status, unrelated to an acute event (Jessen et al., 2020; Jessen et al., 2014); 2) normal age- 
and education- adjusted performance on standard cognitive tests including a word list recall 
score of >5 on the Consortium to Establish a Registry for Alzheimer’s Disease (Morris et al., 
1989), a score on the Weschler Memory Scale (WMS-III) Logical Memory II (i.e., delayed 
recall; Weschler, 1987) above ADNI education-adjusted cut-offs, and a score of ≥ 26 on the 
Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005); 3) a score of 0 on the Clinical 
Dementia Rating (CDR; Hughes, Berg, Danziger, Coben, & Martin, 1982). Other SCD exclusion 
criteria include: surgery within the last 2 months, history of intercranial surgery, regular use of 
benzodiazepines, comorbid condition that is likely to result in death within three years, and age 
being less than 60 years.  
MCI Criteria 
Participants who were diagnosed with MCI were selected based on the following criteria: 
1) concern regarding a change in cognition from previous levels based on the participant’s or an 
informant’s report (Albert et al., 2011); 2) impairment in one or more cognitive domains that is 
greater than what would be expected for the patient’s age and education: WMS-III Logical 
Memory II score below education-adjusted ADNI cutoffs, CERAD word list recall score less 
than 6, global CDR score > 0, and MoCA score between 13-24; 3) assigned a CDR score of ≤ .5 




abilities by having a score greater than 14/23 on the Lawton-Brody Instrumental Activities of 
Daily Living (IADL) scale. Participants must also have an absence of diffuse subcortical 
cerebrovascular disease to be classified as MCI. 
AD Criteria 
Participants who were diagnosed with AD were selected based on the following criteria: 
1) gradual and progressive change in memory and/or other cognitive functions over more than 
six months based on the participant’s and/or informant’s report; 2) objective evidence of 
significant decline in at least 2 cognitive domains by satisfying 2 or more of the following: 
WMS-III Logical Memory II score below ADNI cut-offs, a CERAD word list recall score of <6, 
MoCA score between 13-24 inclusive (with at least one point lost in a non-memory task), and a 
“yes” response to whether the participant has had any changes in personality or behaviour; 3) 
evidence of impairment of functional abilities by responding “yes” to whether cognitive deficits 
interfere with independence in everyday activities (e.g., paying bills, managing medications). 
There must also be no evidence for another concurrent and active neurological disease, a non-
neurological medical comorbidity, or use of medication that could have a substantial effect on 
cognition.  
Measures of Visual Function 
 
MNRead Acuity Charts 
The MNRead Acuity Charts measure reading acuity, the ability to discern sentences at a 
given distance, by assessing reading performance depending on various font sizes (Mansfield, 
Legge, Luebker, & Cunningham, 1994). For this task, participant read sentences on a chart, which 




eyes to the chart. Participants were instructed to read the sentences on the chart aloud starting from 
the top until they could not read any words in a sentence using both eyes. 
Reading acuity was operationalized as the smallest print size at which the participant can 
read the entire sentence without making significant errors (measured to the nearest 0.1 logMAR). 
Reading acuity was measured as the logMAR of the last sentence the participant was able to read. 
A more precise calculation was determined based on the number of sentences correctly read and 
errors made (e.g., words read incorrectly or missed). Per the MNRead scoring instructions, the 
formula for calculating reading acuity is as follows: [acuity = 1.4 – (amount of all sentences read 
x 0.1) + (total amount of errors x 0.01)]. 
The MARS Contrast Sensitivity Test 
The MARS Contrast Sensitivity Test was used to assess contrast sensitivity, the ability to 
distinguish an object from its background, by measuring resolution of the eyes in processing letters 
at different spatial frequencies (Dougerty, Flom, & Bullimore, 2005). For this task, participants 
must read letters on a chart, which was held by the participant with a distance of 50 cm at a 45-
degree angle from the participant’s eyes to the chart. Participants were instructed to read the letters 
from the left to the right of each line, from the top to the bottom of the chart using both eyes. 
Testing was discontinued when the participant made two consecutive errors. 
Contrast sensitivity was operationalized as the final correct letter read by the participant. 
Per the MARS manual, the logCS was calculated by identifying the value at the lowest contrast 
letter prior to two incorrectly identified letters and subtracting it by the number of errors prior to 
the final correct letter. There was one missing case for this measure in the MCI group, which was 





MRI Data Acquisition and Analyses 
MRI Data Acquisition 
T1-weighted images were obtained using 3T scanners from different COMPASS-ND sites 
across Canada following the Canadian Dementia Imaging Protocol (CDIP), which is a harmonized 
and validated protocol for MRI data acquisition available for GE, Philips, and Siemens scanners 
(Duchesne et al., 2019). Parameters for the acquisition of 3D T1-weighted images differed 
depending on the scanner type and version (see https://www.cdip-pcid.ca/ for details on all 
parameters). The T1-weighted images were then processed using the Civet pipeline (version 
1.1.11) at McGill University to extract cortical volumes (gray matter in left and right frontal, 
temporal, occipital, parietal lobes) and conduct structural image analysis (Ad-Dab’bagh et al., 
2006; Zijdenbos, Forghani, & Evans, 2002).  
Cortical reconstruction and segmentation of the T1-weighted images were further 
performed using FreeSurfer (version 6.0, documented online and freely available on 
http://freesurfer.net/). The FreeSurfer pipeline performs surface-based morphometry (SBM) using 
several processing steps described extensively in previous literature (Dale, Fischl, & Sereno, 1999; 
Fischl & Dale, 2000; Fischl et al., 2004). The fully automated pipeline generates individual cortical 
surface models with high spatial precision on a web-based analysis software called CBrain. Five 
participants (2 MCI, 3 AD) were excluded due to preprocessing errors. All brain scans were then 
manually checked for segmentation precision, with no further participants removed.  
Regions-of-interest Analyses 
 Following the preprocessing procedure, the cortex was further parcellated into regions of 
interest (ROIs) using the Destrieux cortical atlas (Destrieux, Fischl, Dale, & Halgren, 2010), which 




curvature and convexity. For example, the occipital lobe can be divided into areas such as the 
parieto-occipital sulcus, anterior occipital sulcus, occipital pole, calcarine sulcus, and so forth, 
which allows for the extraction of cortical thickness and cortical volume at each vertex of the 
occipital area. Cortical thickness is estimated as the minimal distance between gray or white matter 
and the tessellated pial surface at each location in the brain (Fischl & Dale, 2000). This calculation 
has previously been validated against histological analysis and manual measurements and has been 
shown to be reliable in healthy older adults (Liem et al., 2015). Cortical volume is the product of 
both thickness and surface area. Cortical thickness and volume were analyzed for selected ROIs 
(defined by the Destrieux atlas) using standard procedures for ROI extraction in FreeSurfer.  
Our ROIs were selected based on the specific vision-related areas examined by other 
studies that have investigated the relationship between profound visual impairment and structural 
decline, or areas that were associated with processing of reading acuity and contrast sensitivity. 
For more information regarding justification and choice of ROIs, please refer to our objectives 
and rationale section.  
Aside from visual-related regions, we also looked at cortical thickness and volume in the 
precentral and postcentral gyri in the motor cortex. As motor areas tend to be relatively spared in 
early stages of AD (see Mann, 1991; Baron et al., 2001; Fox et al., 2001; Whitwell, 2010 for a 
review), these regions served as control areas to compare any significant effects we saw for 
visual-based ROIs. This would determine whether our findings between diagnostic groups were 
specific to visual-based regions of the brain and not just a result of generalized atrophy 




Statistical Analyses  
Data analyses were completed using R and RStudio (Version 3.6.0). Data were first 
assessed for missing data, data entry errors, and out of range outliers (+/- 3 SD). Assumptions of 
normality (using histograms, skewness and kurtosis values, and statistical normality tests 
including the Kolmogorov-Smirnov and Shapiro-Wilk) and homogeneity of variance (Levene’s 
Test) were also checked. We used age, sex, and education as covariates in all statistical analyses 
based on group differences (see Table 1). In analyses involving cortical structure, we also 
included intracranial volume (ICV) as a covariate in order to control for potential differences in 
premorbid brain volume between groups (Voevodskaya et al., 2014). Along with basic 
demographic analyses (i.e., age, sex, education) between groups, we conducted Chi-squared tests 
for independence to determine whether comorbid eye-related disease or visual deficits were 
significantly related to diagnostic group membership (see Table 1 for all Chi-square results).  
To assess our first objective, the diagnostic groups were first compared in their 
performance on the vision measures (i.e., reading acuity and contrast sensitivity) using one-way 
ANCOVAs. For pairwise comparisons, we conducted post-hoc tests with Bonferroni adjustment 
for multiple comparisons and calculated Cohen’s d to estimate effect size between groups. To 
address our second objective, we conducted hierarchical (sequential) regression models to 
determine whether visual performance predicted cortical structure over and above group 
membership. For each outcome variable (cortical volume and cortical thickness), a family of four 
hierarchical regressions were conducted for each of the 9 ROIs in each hemisphere. All regressions 
had the same predictor variables entered at the same step for all four models. All continuous 
predictors (age, years of education, ICV, reading acuity scores, contrast sensitivity scores) were 




diagnostic group), SCD women were used as the referent group. Pairwise comparisons between 
the MCI and AD groups were also done for each regression to assess group-specific relationships 
between visual performance and brain structure. In the first model, demographic predictors of age, 
sex, education, and total ICV were used to predict thickness or volume in each ROI. In the second 
model, diagnostic group was added as a predictor as previous literature has established that cortical 
structure differs based on diagnostic group (Dickerson et al., 2009; Gili et al., 2010; Kiuchi et al., 
2014). In the third model, both reading acuity and contrast sensitivity scores were added as 
variables of interest to determine if performance on visual tests predicted a significant amount of 
additional variance in cortical thickness and volume. Based on limited theoretical and logical 
rationale for whether reading acuity or contrast sensitivity would explain more variance in cortical 
structure, both measures were entered in the third model simultaneously. In the fourth and final 
model, diagnostic group was set to interact with reading acuity and contrast sensitivity scores to 
determine whether the relationship between visual performance and cortical structure differed by 
group (i.e., whether the interaction between visual performance and group explained variance 
beyond the separate main effects of visual performance and diagnostic group in Models 2-3).  
Analysis of the best predictive model and influence of each predictor in explaining the variance in 
cortical structure was done primarily by running an ANOVA between the four models with an 
alpha level of .05; moreover, R2 change and Akaike Information Criterion (AIC; lowest AIC score 
is the best model across all ranked models; Bozdogan, 1987) values were also examined to 






There were two outliers (+/3 SD) identified for reading acuity (i.e., 1 in the MCI group, 1 
in the SCD group) and no outliers for cortical structure in all ROIs. Assumptions of normality 
(skewness and kurtosis per guidelines by Kline, 2016) were met for all variables. Assumptions of 
homogeneity of variance were met for most outcome variables, except for left parieto-occipital 
sulcus thickness. We ran a non-parametric Kruskal-Wallis test to assess this violation, which 
indicated a statistically significant difference in left parieto-occipital thickness between the three 
independent groups. Mann-Whitney U tests were also conducted to determine the significant 
main effect between independent groups on this variable. 
Table 1 lists the demographics and descriptives on visual measures for each diagnostic 
group. There were significant group differences for age, sex, and education, which were used as 
covariates in all further analyses. The AD group was significantly older, with fewer years of 
education, compared to the SCD and MCI groups. Moreover, there was a significant difference 
in sex over the diagnostic groups, such that the AD group was largely male (66.6%) and the SCD 
group was largely female (77.5%; see Table 1). There were also significant group differences for 
visual field loss and AMD between diagnostic groups. For visual field loss, the AD group had 
the highest percentage of visual field deficits, followed by the MCI group. For AMD, the AD 
group had the greatest percentage of AMD cases followed by the SCD group, which was 
followed by the MCI group. Results from these post-hoc tests assessing violation of homogeneity 
in variance indicated a statistically significant difference in left parieto-occipital sulcus thickness 
between SCD and MCI groups, as well as SCD and AD groups. However, this was not corrected 
as the difference in cortical thickness between the SCD group and the MCI and AD groups may 




Diagnostic Group Comparisons in Visual Function  
 
 Figure 1 shows a categorical distribution of performance on both vision measures across 
the entire sample. Most participants demonstrated normal reading acuity and contrast sensitivity 
(92% of SCD, 90% of MCI, 64% of AD) compared to low reading acuity and normal contrast 
sensitivity (2% of SCD, 1% of MCI, 2% of AD), normal reading acuity and moderate-severe 
contrast sensitivity (6% of SCD, 9% of MCI, 27% of AD), and low reading acuity and moderate-
severe contrast sensitivity (0% of SCI, 0% of MCI, 7% of AD). For each visual measure, 98% of 
SCD, 99% of MCI, and 91% of AD had normal reading acuity and 94% of SCD, 91% of MCI, 
and 67% of AD had normal contrast sensitivity. 
There was a significant difference between diagnostic groups in reading acuity 
performance (F(2,200) = 3.59, p < .01; see Figure 2) and in contrast sensitivity performance 
(F(2,200) = 10.29,  p < .01; see Figure 3). Post-hoc tests demonstrated that the AD group (.21 ± 
.03) performed significantly worse on reading acuity compared to the SCD (.10 ± .03, p = .01, d 
= -3.67) and MCI groups (.13 ± .02, p = .02, d = -3.41), with no statistically significant 
difference between the SCD and MCI groups (p = 1.00, d = -1.26). Post-hoc tests also showed 
that the AD group (1.58 ± .02) performed significantly worse on contrast sensitivity compared to 
the SCD (1.71 ± .02, p < .01, d = 6.5) and MCI groups (1.70 ± .02, p < .01, d = 6.00), with no 
statistically significant difference between the SCD and MCI groups (p = 1.00, d = .5). 
Predicting Cortical Structure by Diagnostic Group and Visual Performance 
 
 To preview the results, our hierarchal regressions demonstrated that visual performance 
did not explain more variance in vision-related cortical structure in both hemispheres beyond 




40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72 for thickness and volume in the 
left and right hemisphere of all nine ROIs).  
Left Hemisphere 
Having controlled for age, sex, education, and total ICV, and holding SCD women as the 
as reference group, we found that group membership (Model 2) explained a significant amount 
of variance in cortical structure and was selected as the best predictive model for most areas 
compared to Models 3 and 4.   
Cortical Volume. Group membership was selected as the best predictive model for 
multiple areas, including the left inferior occipital gyrus (an additional 3.8% of variance; SCD > 
AD; see Tables 2-3), the left cuneus (an additional 3.8% of variance; SCD > AD; see Tables 6-
7), the left middle occipital gyrus (an additional 2.4% of variance; SCD > AD; see Tables 10-
11), and the left parieto-occipital sulcus (an additional 6.7% of variance; SCD, MCI > AD; see 
Tables 34-35). In no cases did Models 3 and 4 (i.e., visual performance) significantly account for 
greater than 1.5% of variance in cortical volume, in any of the nine ROIs. 
Cortical Thickness. Group membership was selected as the best predictive model for 
multiple areas, including the left inferior occipital gyrus (an additional 6.8% of variance; SCD > 
AD; see Tables 4-5), the left middle occipital gyrus (an additional 3% of variance; SCD > AD; 
see Tables 12-13), the left lunate sulcus (an additional 4.8% of variance; SCD, MCI > AD; see 
Tables 16-17), the left occipital pole (an additional 2.9% of variance; SCD > MCI, AD; see 
Tables 24-25), the left calcarine sulcus (an additional 2.2% of variance; SCD > MCI, AD; see 
Tables 28-29), the left anterior occipital sulcus (an additional 7.5% of variance; SCD, MCI > 
AD; see Tables 32-33), and the left parieto-occipital sulcus (an additional 3.8% of variance; 




significantly account for, in any of the 9 ROIs, greater than 1.1% of variance in cortical 
thickness.   
Right Hemisphere  
Similar to regressions in the left hemisphere, group membership (Model 2) was identified 
as the best predictive model for most areas.  
Cortical Volume. Group membership was selected as the best predictive model for 
cortical volume in the right cuneus (an additional 2.8% of variance; SCD, MCI > AD; see Tables 
42-43), the right middle occipital gyrus (an additional 3.4% of variance; SCD, MCI > AD; see 
Tables 46-47), the right occipital pole (an additional 8.3% of variance; SCD, MCI > AD; see 
Tables 58-59), and the right parieto-occipital sulcus (an additional 5.7% of variance; SCD, MCI 
> AD; see Tables 70-71). In no cases did Models 3 and 4 (i.e., visual performance) significantly 
account for, in any of the 9 ROIs, greater than 1.3% of variance in cortical volume. 
Cortical Thickness. Group membership was selected as the best predictive model for 
cortical thickness in the right lunatus sulcus (an additional 5.2% of variance; SCD, MCI > AD; 
see Tables 52-53), the right superior occipital gyrus (an additional 2.2% of variance; SCD > AD; 
see Tables 56-57), the right occipital pole (an additional 2.9% of variance; SCD > AD; see 
Tables 60-61), the right calcarine sulcus (an additional 5.8% of variance; SCD > AD; see Tables 
64-65), and the right parieto-occipital sulcus (an additional 5.7% of variance; SCD > AD; see 
Tables 72-73). In no cases did Models 3 and 4 (i.e., visual performance) significantly account 
for, in any of the 9 ROIs, greater than 1.3% of variance in cortical thickness. 
Group Differences in Cortical Structure in Motor Areas 
Our results demonstrated no significant differences across or between groups for the 




the left precentral and postcentral gyri and Tables 78-81 for results on cortical volume and 







The goal of our study was to characterize visual function in individuals with or at risk for 
dementia and explore the effects of this sensory-cognitive relationship on brain structure.  Our 
findings indicate that older adults with dementia (AD) present significantly worse visual 
functioning compared to older adults at risk for dementia (SCD and MCI groups). Despite our 
findings that visual performance differs across diagnostic groups and that group membership 
predicted cortical structure, our results demonstrate that visual performance does not predict 
cortical structure above and beyond group membership. Although previous literature has 
established that AD participants demonstrate poor visual performance, we are the first to 
characterize and explore visual function for all three diagnostic groups with varying clinical 
pathology. Moreover, our findings provide new insights into the sensory-cognitive-brain 
relationship and are the first to investigate vision and the sensory deprivation hypothesis in older 
adults with or at risk for dementia.  
Visual Performance in Older Adults with AD 
We assessed whether visual performance on measures of reading acuity and contrast 
sensitivity differed across groups. We found that the AD group demonstrated both poorer reading 
acuity and contrast sensitivity compared to the SCD and MCI groups, even when controlling for 
age, sex, and education. There were no significant differences between the MCI and SCD 
groups; moreover, visual function in the SCD and MCI groups were mostly within the normal 
range, which characterizes visual function in pre-clinical groups at risk for dementia. First, these 
results suggest that vision impairment may only be evident in later stages of AD progression. 
Second, 91% of AD had normal reading acuity and 67% of AD had normal contrast sensitivity. 




and contrast sensitivity compared to the other two groups, the majority of AD individuals 
perform within the normal range on both measures. This suggests that their visual difficulties, 
overall, are not severe or of clinical significance. Moreover, our observed deficits in reading 
acuity and contrast sensitivity in AD may indicate AD-related changes associated with 
neuropathologic and/or functional changes in the retina and/or visual processing pathways.  
We do not believe that our findings on visual function were driven by presence of co-
morbid diseases or other visual deficits. Although there was a significant group differences of 
AMD diagnosis (the MCI group had a higher percentage of cases compared to the SCD and AD 
groups), our results on visual function follow a different pattern (the SCD and MCI groups had 
better visual performance compared to the AD group; see Table 1). There was also a group 
difference in visual field deficits (the SCD group had a lower percentage of visual deficits than 
the MCI group, which had a lower percentage of visual deficits than the AD group; see Table 1); 
however, the difference between SCD and MCI groups is small (0% in SCD, and 1% in MCI) 
and is likely unreliable. Moreover, classification of visual field deficits was based only on one 
clinical test done during the COMPASS-ND neurology exam and did not comprehensively 
assess true visual field function. Therefore, this suggests that the relationship between diagnostic 
group membership and visual function is not confounded by presence of concurrent eye-related 
diseases or visual deficits. In support of our results, other studies have also indicated no group 
differences among SCD, MCI, and AD in previously diagnosed eye-related disorders (Marquie et 
al., 2019).  
Previously, cross-sectional research has found worse performance for visual acuity 
(Uhlmann et al., 1991; Rizzo et al., 2000) and contrast sensitivity (Hutton et al., 1993; Rizzo et 




to healthy controls. Our finding that the AD group demonstrated poorer reading acuity compared 
to the SCD and MCI groups supports a recent study by Marquie et al. (2019), who also found 
that AD patients present worse visual acuity compared to SCD and MCI groups. In another 
study, Risacher et al. (2013) demonstrated that both AD and MCI groups demonstrate poor 
contrast sensitivity compared to individuals with cognitive complaints (SCD). This is somewhat 
in contrast with our findings, as both SCD and MCI groups were similar in performance on both 
measures of reading acuity and contrast sensitivity. This difference may be due to few reasons. 
First, our AD and MCI groups were similar in age (~76 years) and significantly older than the 
SCD group in the Risacher et al (2013) study, whereas the SCD and MCI groups were similar in 
age (SCD age = ~70 years, MCI = ~71 years) and significantly younger than the AD group in 
our study. Second, Risacher et al (2013) used a complex measure of visual field contrast 
sensitivity that evaluated 55 regions in each eye, which provided comprehensive analysis of 
contrast sensitivity thresholds, overall contrast sensitivity in each eye, and standard deviation to 
indicate how it deviates from age-adjusted norms. In comparison, we used the MARS Contrast 
Sensitivity test, which assesses letter contrast sensitivity at low retinal spatial frequencies on a 
chart. Variability in both the type of contrast sensitivity measure and the complexity of the 
measure itself could have contributed to differences in our findings and those of Risacher et al. 
(2013). 
Finally, our findings demonstrate a consistent pattern across both visual measures and 
diagnostic groups (AD has reliably worse visual performance than SCD and MCI), suggesting 
that the AD group has significantly poor vision function compared to pre-clinical groups with 
less AD pathology. It is possible that any difference in visual deficits between SCD and MCI 




function with more prominent clinical pathology (AD). This is substantiated by other cross-
sectional studies that associate poor visual function with AD pathology (Marquie et al., 2019; 
Risacher et al., 2013) and poor cognitive function quantified by MMSE scores (Zheng et al., 
2018; Spierer et al., 2016; Mine et al., 2016) and other neuropsychological tests (Chen et al., 
2017). Therefore, our study adds to previous literature by characterizing visual performance on 
multiple visual measures for all three diagnostic groups with or at risk for dementia.  
Group Membership Predicts Variance in Cortical Structure for Multiple ROIs 
Based on our hierarchical regression analyses, we found that group membership predicted 
cortical structure for multiple ROIs in each hemisphere beyond the baseline model predictors of 
age, sex, education, and ICV. In general, the AD group showed reduced cortical volume 
compared to the SCD group in the left inferior occipital gyrus and middle occipital gyrus, and in 
cortical thickness in the left inferior occipital gyrus and middle occipital gyrus, and the right 
superior occipital gyrus, calcarine sulcus, and parieto-occipital sulcus. Moreover, the AD group 
showed reduced cortical volume compared to both the SCD and MCI groups in the left-parieto 
occipital sulcus and the right cuneus middle occipital gyrus, occipital pole, and parieto-occipital 
sulcus, and in cortical thickness in the left anterior occipital sulcus and parieto-occipital sulcus 
and the right lunatus sulcus. Finally, both the MCI and AD groups showed reduced cortical 
thickness compared to the SCD group in the and between the SCD group left occipital pole and 
calcarine sulcus. These results present that overall, the AD group demonstrates more cortical 
atrophy in multiple vision-related ROIs compared to the SCD and MCI groups.  
Reduced cortical integrity in AD individuals has been previously substantiated by 
multiple studies. Cortical atrophy has been supported as a neurological marker of increasing AD 




Muramatsu, 1994). Relevant to our study, there have been some findings demonstrating cortical 
degeneration in visual-related regions in AD groups. AD patients present degeneration in the 
primary visual cortex and secondary visual association cortices (Brewer & Barton, 2014; 
Armstrong, 1996; Lewis et al., 1987; McKee et al., 2006), as well as of subcortical regions 
comprising parts of the visual pathway (e.g., lateral geniculate nucleus; Leuba & Saini, 1995) 
and degeneration of the optic nerve and retinal ganglion cells (Hinton et al., 1986; Danesh-
Meyer, Birch, Ku, Carroll, & Gamble, 2006; Berisha et al., 2007). Other findings present 
different patterns of atrophy in early-and late-onset individuals with AD. Whereas AD 
individuals with early-onset have atrophy in the neocortex and occipital lobe (sparing the 
primary but not the secondary visual cortex), those with a late-onset have diffuse loss that is 
prominent in the medial-temporal area (Frisoni et al., 2007). Together, these studies substantiate 
our finding of atrophy in visual-related ROIs in the AD group.   
Although the current consensus is that primary sensory and motor areas are left relatively 
spared or affected at later stages of AD, previous literature and histology studies have found AD 
pathologies in the primary visual cortex and visual association areas (Leuba & Saini, 1995; 
Lewis et al., 1987; McKee et al., 2006). In fact, McKee et al.’s (2006) findings indicate that 
posterior visual areas can be affected even in the early stages of AD. In comparison, there is 
substantive evidence to establish that the motor cortex is often less affected in advanced stages of 
AD compared to the medial-temporal lobe and surrounding parietal-temporal-occipital 
association areas (Mann, 1991; Baron et al., 2001; Fox et al., 2001; Whitwell, 2010). To our 
knowledge, our study is the first to assess differences in cortical atrophy between clinical groups 
in both the primary motor and vision areas. Similar to previous findings, we found significant 




precentral and postcentral gyrus (i.e., motor areas). This suggests that cortical atrophy is specific 
to the visual cortex and not simply a result of generalized atrophy throughout the brain in AD 
individuals. Finally, given these neurodegenerative changes in visual areas for AD individuals, it 
may not be surprising that we also found higher-order visual deficits involving reading acuity 
and contrast sensitivity in the AD group.  
Visual Performance does not Predict Cortical Structure beyond Group Membership 
With our hierarchal regression analyses, we found that there were no ROIs in which 
visual performance or the interaction between visual performance and group membership 
significantly accounted for variance in cortical integrity once we accounted for age, sex, 
education, ICV, and group membership alone.  Thus, visual function or the visual-cognitive 
association do not predict cortical thickness and volume over and above group membership, in 
contrast to our hypothesis.  
Our findings support two independent links, in that there is a link between 1) vision and 
group membership and 2) between group membership and cortical integrity, with no independent 
or direct link between visual status and cortical integrity. Despite poorer performance on reading 
acuity and contrast sensitivity in AD, our study has demonstrated that it is not visual status that 
drives the cortical atrophy patterns we see in visual ROIs in AD individuals. Similarly, we can 
conclude that although the AD group does have cortical atrophy in the visual cortex and related 
association areas, it is not visual status or visual performance that is largely contributing to this 
atrophy.  
Our findings provide insight on the sequence and pathological mechanisms at play behind 
the vision-cognition-brain relationship. Whereas the sensory deprivation hypothesis posits that 




results instead support a hypothesis in a different direction, such that neuropathology due to AD 
contributes to atrophy in vision-related brain regions that affects functional visual performance. 
This may explain why visual performance was poorer in the AD groups compared to other 
groups with less cognitive pathology, although it did not specifically predict cortical atrophy in 
vision-related brain regions. Perhaps then, deficits or changes in visual performance may also be 
explained by the measure being used, especially when adequate performance on that specific 
measure (e.g., contrast sensitivity) requires integrity of the underlying visual areas that are 
affected by AD pathology. Moreover, it is possible that the visual measure itself (e.g., reading 
acuity) may require optimal cognitive function to perform adequately. Although oral reading is 
thought to be relatively preserved at least during early stages of AD (Friedman, Ferguson, 
Robinson, & Sunderland, 1992; Strain, Patterson, Graham, & Hodges, 1998), others have found 
that reading and understanding meaning of written words are impaired in individuals with AD 
due to difficulties with visual processing and analysis of linguistic stimuli (Glosser et al., 2000). 
To address this in our study, we briefly tested and found that reading deficits (measured by 
neuropsychological tasks of sentence and word reading) did not significantly explain 
performance on our vision measures of reading acuity and contrast sensitivity. 
There is enough evidence in our findings to retain the common-cause hypothesis. The 
common-cause hypothesis traditionally suggests that one or more underlying factors contribute 
to the development of both sensory and cognitive impairment, more specifically, a common 
factor contributes to both visual and cognitive decline. Our findings did not support a causal 
relationship between a) greater cortical atrophy in AD and b) poor visual performance in AD, 
and instead suggest that there are other factors beyond visual status are contributing to cortical 




neurofibrillary tangles, amyloid beta deposits, inflammation) at various levels of the visual 
pathway (e.g., retina, optic nerve, subcortical regions, cortical regions associated with visual 
function; Leuba & Sani, 1995; Ikram et al., 2012; McKee et al., 2006), which may contribute to 
both poor visual function and accelerated cortical atrophy in vision-related brain regions. 
Risacher et al. (2013) have similarly hypothesized that the observed visual deficits in individuals 
with MCI and AD reflect neuropathological changes in the retina and central visual processing 
pathways. To further support our theory, tau and amyloid pathology have been associated with 
increased neurodegeneration and rates of region-specific cortical atrophy in both cognitively 
normal older adults and in individuals with MCI and AD (see Bejanin et al., 2017; Chételat et al., 
2012 for examples). However, it remains critical to note that our study did not assess measures of 
neuropathology across different levels of the visual system, and our conclusions remain 
speculative at best until further research is completed.  
The pathological mechanisms underlying changes in contrast sensitivity and other low-
level visual measures in AD have been previously discussed. Cronin-Golomb et al. (1991a), 
Cronin-Golomb et al. (1991b) and Leuba and Sani (1995) hypothesized that atrophy or lesions in 
the primary and associative visual cortex were responsible for the psychophysical visual deficits 
(e.g., in contrast sensitivity) observed in AD individuals, and that the pattern of performance on 
vision measures may elucidate the location and extent of underlying cortical atrophy that 
contributes to visual dysfunction in AD. In conjunction with atrophy in the cortex, other 
researchers have attributed visual problems to pathological changes or abnormalities in 
peripheral structures such as the optic nerve and retina (Gilmore & Whitehouse, 1995; Hinton et 
al., 1986; Sadun & Bassi, 1990; Bassi et al., 1993; Risacher et al., 2013). Overall, based both on 




group membership drives visual performance, 2) deficits or changes in visual performance are 
pronounced when the measure relies on the integrity of underlying visual areas that are affected 
by AD pathology, and that 3) one area of future research is to assess the mechanisms and extent 
to which both cortical and retinal (e.g., degeneration of visual pathways, the optic nerve) 
pathology contribute to behavioural visual deficits in AD.  
Limitations 
Although our MCI group had a substantial sample size, we need additional data to obtain 
greater power and less variability in results for the SCD and AD groups. It is possible that 
smaller sample sizes for the SCD and AD groups could contribute to null effects or small effects 
that do not reach statistical significance although in the right direction. Increasing our sample 
size in these two groups will allow better estimates of effect size, especially with FreeSurfer 
analyses. Another limitation regarding our sample size is the skewed sex ratio of the SCD (78% 
women) and AD (33% women). This may not be representative of the population, especially 
given the fact that AD is more prevalent in women than men (see Baum, 2005 for a review).  
 Other shortcomings involve the scope and extent of the measures that were available in 
the COMPASS-ND dataset. One limitation is that we used a complex measure of reading acuity 
compared to a basic-level assessment of visual acuity, such as grating acuity. Reading acuity is a 
functional test of reading performance that measures not only threshold size, but also involves 
components of reading such as fluency, speed, and comprehension (Colenbrander, 2005; Xiong 
et al., 2018). It is also possible that high-contrast reading acuity may be too robust as a visual 
skill to be sensitive to subtle cortical changes, compared to low-contrast acuity (grey on white). 
Moreover, it is important to remember that we only used two visual measures to determine visual 




ROIs remains largely understudied, domains of color vision, depth perception, basic-level visual 
acuity, or visuospatial processing have all been implicated clinically in AD individuals and may 
contribute to stronger associations with atrophy in vision-related areas. To obtain a more 
comprehensive characterization of visual function in our participants, we could have measured 
peripheral vision (e.g., a complex measure of visual field deficits), retinal thickness, or amyloid 
deposits in the retina. There were also were no structural data in the COMPASS-ND dataset for 
important visual areas like the superior colliculus and pulvinar, which have been implicated as 
pathological structures underlying visual deficits in AD individuals (Iseki et al., 1989; Rizzo et 
al., 2000).   
Finally, our study only assessed cross-sectional data. In order to clarify the direction of 
the vision-cognitive relationship and its influence on cortical structure, longitudinal data are 
needed (which are currently being collected in the COMPASS-ND study). Although our study is 
the first to assess the visual-cognition-brain relationship in multiple groups with varying 
cognitive function, longitudinal data will be critical in revealing core directions or causal 




Implications and Future Directions 
These data give first insights into the frequency and degree of visual impairment in 
clinical groups with or at risk for dementia in the COMPASS-ND dataset, allowing us to explore 
the relationship between vision, cognition, and cortical structure in our participants. Given that 
we found poorer visual performance in the AD group compared to the SCD and MCI groups, and 
that visual impairment and cognitive decline are major health issues for older adults, our research 
supports efforts of targeting and treating poor vision (e.g., regular ophthalmological assessments) 
in preclinical stages of AD and AD to optimize visual function.  
Future studies will be helpful in clarifying which specific visual measures (e.g., contrast 
sensitivity) are useful in predicting early MCI or AD and are promising tools for dementia 
screening. Moreover, deficits in contrast sensitivity can also lead to degraded visual input and 
consequently contribute to functional impairment, such as difficulties with mobility and 
navigating around obstacles, and greater risk for falls (see Cormack et al., 2000 for a review). 
Research investigating functional impairment caused by visual deficits can potentially have 
profound clinical implications. For example, we can ascertain the relationship between visual 
function and activities of daily living across the diagnostic groups in order to assess and improve 
quality of life.  
Our study adds to previous sensory-cognitive literature and provides novel insight on the 
mechanisms underlying the sensory-cognitive-brain relationship; more specifically, the 
association between functional visual impairment in AD and structural atrophy in the visual 
system. It would be useful to further determine patterns and rates of atrophy present in the 
primary visual cortex and secondary visual association areas, and consequently ascertain how 




visual deficits, above and beyond changes in hippocampal and medial-temporal areas. Moreover, 
additional research needs to be done to determine the pathological substrates underlying changes 
or deficits in visual function; more specifically, future research should delineate whether visual 
deficits are attributable to structural atrophy in central vision areas as a consequence of AD 
pathogenesis, pathological changes in peripheral structures like the retina and optic nerve that 
affect visual input, or deterioration and pathology in both.   
More research also needs to be done to determine which clinical or neuropathologic 
factors accelerate cortical atrophy in vision-related areas in AD to facilitate identification of 
biomarkers that increase both visual and cognitive decline. With additional longitudinal data 
from the COMPASS-ND dataset, we may be able to identify visual impairment as a possible risk 
factor associated with developing AD or determine whether improving visual function is a 
promising opportunity for dementia prevention. Such studies will facilitate development of 
strategies and novel interventions that provide ways to detect and improve visual deficits to 
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Basic Demographics and Descriptives on Vision Variables and Counts of Eye-Related Diseases 
and Visual Deficits for SCD, MCI, and AD Groups 
 SCD  
(N = 53) 
MCI  
(N = 102) 
AD  




 Mean ±SD Mean ±SD Mean ±SD  F Post-hoc X2 





16.95 3.16 15.67 3.98 14.88 3.79  3.96* SCD, MCI> 
AD 
-  
Female (%) 77.5 46.1 33.3  - - 21.34*
* 
           
Vision 
Variables 




.11 .14 .12 .17 .22 .21  3.59** SCD, MCI > 
AD 
-  
MARS CS (log 
CS2) 
1.73 .13 1.70 .15 1.57 .18  10.29*
* 
SCD, MCI > 
AD 
-  










   
Diabetes Type I 
(%) 
0 2 0  - - 1.94 
Diabetes Type 
II (%) 
2 11 3  - - 2.50 
Cataracts (%) 20 41 18  - - .12 









0 1 3  - - 
6.62* 
Note. * p = <.05, ** p = <.01 
1 controlling for age and sex; logMAR = logarithm of the minimum angle of resolution; lower 
score indicates better performance; logMAR < .30 (equivalent of better than 20/40) = normal 
acuity. logMAR .30 to .50 (20/40 to 20/60) = moderate visual impairment 
2 controlling for age and sex; higher score indicates better performance; < 1 log CS = severe 
impairment, 1-1.5 log CS = moderate impairment, > 1.5 log CS = normal for age 60+ 
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Table 2  
 
Regression Models for the Volume of the Left Inferior Occipital Gyrus  
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age 9.53 38.47 -66.34 – 
85.39 
33.93 38.50 -42.01 – 
109.87 
38.7 40.09 -40.37 – 
117.77 
39.69 40.92 -41.03 – 
120.42 
Sex  75.46 80.2 -82.71 – 
233.62 
139.09 81.87 -22.38 – 
300.57 
153.29 82.53 -9.5 – 
316.08 
155.79 84.96 -11.83 – 
323.4 
Education 105.3** 38.55 29.26 – 
181.33 
83.5* 38.43 7.69 – 
159.3 
85.59* 38.5 9.66 – 
161.53 
81.37* 39.38 3.67 – 
159.06 
ICV 88.4* 39.86 9.78 – 
167.02 
98.49* 39.19 21.19 – 
175.79 
101.01* 39.25 23.59 – 
178.44 




   -150.95 93.38 -336.31– 
34.40 
-154.33 94.17 -340.07 – 
31.4 




   370.41** 117.04 -601.25 – 
-139.56 
365.78** 122.12 -606.65 –   
-124.9 
301.17* 132.1 -561.79 – 
- 40.55 
RA       55.21 43.73 -31.05 – 
141.46 
105.05 100.07 -92.38 – 
302.47 
CS       50.07 47.08 -42.80 – 
142.94 
9.37 99.9 -187.72 – 
206.47 
Group x Vision            
MCI x RA         -39.21 118.71 -267.12 – 
201.29 
AD x RA         -68.11 142.37 -349.01 – 
212.78 
MCI x CS         14.94 118.36 -218.59 – 
248.44 




.05 .09 .09 .07 
AIC  3091.47 3085.19 3087.19 3097.39 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Inferior Occipital Gyrus  
Group Estimated Marginal Mean SE 95% CI 
SCD 2956 77.1 2804 – 3108 
MCI 2805 52.6 2701– 2909 
AD 2585 82.1 2424 – 2747 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 151 94.0 1.61 .25 
SCD – AD 370 117.0 3.17 .01 
MCI – AD 219 97.3 2.26 .06 
Note. Results are averaged over the levels of sex.   
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Table 4  
 
Regression Models for the Thickness of the Left Inferior Occipital Gyrus  
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .00 .01 -.03 – .03 .01 .01 -.01 – .04 .02 .01 -.01 – .05 .02 .01 -.01 – .05 
Sex  -.02 .03 -.08 – .04  .01 .03 -.05 – .07 .02 .03 -.04 – .07 .02 .03 -0.04 – .08 
Education .04* .01 .01 – .06 .03 .01 -.00 – .05 .03 .01 -.00 – .05 .02 .01 -.00 – .05 
ICV .01 .01 -.02- .04 .01 .01 -0.02 – .04  .01 .01 -.02 – .04 .01 .01 -.02 – .04 
Group 
(MCI) 
   -.07* .03 -.14 – -.00 -.07* .03 -.14 – -.00 -.07 .04  -.14 – .01 
Group 
(AD) 
   -.17*** .04 -.25 – -.09 -0.16*** .04 -.25 – -.07 -.16*** .05 -.25 – -.07 
RA       .02 .02 -.01 – .05 .04 .04 -.03 – .11 
CS       .03 .02 -.01 – .06  .02 .04 -.05 – .09 
Group x Vision            
MCI x RA         -.02 .04 -.1 – .07 
AD x RA         -.04 .05 -.14 – .06 
MCI x CS         .00 .04 -.08 – .08 
AD x CS         -.03 .05 -.13 – .07 
Adjusted 
R2 
.01 .08 .09 .08 
AIC  -73.80 -86.10 -84.68 -75.75 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 






Pairwise Comparisons between Groups in Thickness of the Left Inferior Occipital Gyrus  
Group Estimated Marginal Mean SE 95% CI 
SCD 2.39 .03 2.34 – 2.45 
MCI 2.32 .02 2.29 – 2.36 
AD 2.33 .03 2.16 – 2.28 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .07 .03 2.03 .11 
SCD – AD .17 .04 4.02 .00 
MCI – AD .10 .03 2.88 .01 





Regression Models for the Volume of the Left Cuneus  
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -18.08 37.5 -92.04 – 
55.89 
2.24 37.83 -72.38 – 
76.86 
12.64 39.46 -65.19 – 
90.47 
17.83 40.38 -61.84 – 
97.49 
Sex  38.49 78.19 -115.71 
–192.68 
85.8 80.45 -72.87 – 
244.46 
83.86 81.24 -76.38 – 
244.10 
84.81 83.84 -80.60 – 
250.22 
Education 66.74 37.59 -7.39 – 
140.87 
49.82 37.77 -24.67 – 
124.31 
50.87 37.89 -23.87 – 
125.61 
54.44 38.36 -22.23 – 
131.11 
ICV 94.08* 38.86 17.43 – 
170.72 
102.49** 38.51 26.53 – 
178.45 
102.84** 38.64 26.63 – 
179.06 




   -93.05 92.34 -275.18– 
89.08 
-87.03 92.69 -269.86 – 
95.79 




   -294.34** 115.01 -521.18 – 
-67.51 
-258.27* 120.20 -495.37 –   
-21.8 
-235.06 130.36 -492.25 – 
- 22.13 
RA       -29.43 43.04 -114.33 – 
55.48 
-62.4 98.75 -257.22 – 
132.43 
CS       22.76 46.35 -68.66 – 
114.17 
-36.68 98.58 -231.18 – 
157.82 
Group x Vision            
MCI x RA         81.31 117.15 -149.81 – 
312.43 
AD x RA         8.51 140.5 -268.69 – 
285.70 
MCI x CS         81.64 116.80 -140.80 – 
312.08 




.03 .05 .05 .03 
AIC  3081.26 3078.17 3080.87 3092.09 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 
selected by ANOVA: Model 2 better than Model 1 (F(2,193) = 3.38, p = .04); Model 3 not better than Model 2 (F(2, 191) = .61,  p = .4)  
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Table 7  
 
Pairwise Comparisons between Groups in Volume of the Left Cuneus  
Group Estimated Marginal Mean SE 95% CI 
SCD 2931 75.7 2782 – 3081 
MCI 2838 51.7 2736 – 2940 
AD 2637 80.6 2782 – 2796 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 93.1 92.3 1.01 .57 
SCD – AD 294.3 115.0 2.56 .03 
MCI – AD 201.3 95.6 2.11 .09 





Regression Models for the Thickness of the Left Cuneus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.00 .01 -.02 – .02 .00 .01 -.02 – .02 -.00 .01 -.02 – .02 -.00 .01 -.02 – .02 
Sex  -.02 .02 -.07 – .02  -.02 .02 -.06 – .03 -.02 .02 -.07 – .02 -.02 .02 -0.06 – .03 
Education .01 .01 -.01 – .03 .01 .01 -.02 – .03 .00 .01 -.02 – .03 .00 .01 -.02 – .02 
ICV -.00 .01 -.02 – .02 .00 .01 -.02 – .02  -.00 .01 -.02 – .02 .00 .01 -.02 – .02 
Group 
(MCI) 
   -.01 .03 -.06 – .04 -.01 .03 -.06 – .04 -.01 .03  -.07 – .04 
Group 
(AD) 
   -.04 .03 -.11 – .02 -.04 .03 -.11 – .02 -.04 .04 -.11 – .03 
RA       -.02 .01 -.05 – .00 -.03 .03 -.08 – .03 
CS       -.02 .01 -.04 – .01  -.03 .03 -.08 – .03 
Group x Vision            
MCI x RA         .02 .03 -.05 – .08 
AD x RA         -.02 .04 -.1 – .05 
MCI x CS         .01 .03 -.05 – .06 
AD x CS         .01 .04 -.06 – .07 
Adjusted 
R2 
-.01 -.01 .00 -.02 
AIC  -200.67 -198.73 -199.03 -188.58 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 
selected by ANOVA: Model 2 (F(2,193) = .99, p = .37) and Model 3 (F(2,191) = 2.04, p = .13) not better than Model 1. 
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Table 9  
 
Pairwise Comparisons between Groups in Thickness of the Left Cuneus  
Group Estimated Marginal Mean SE 95% CI 
SCD 1.88 .02 1.83 – 1.92 
MCI 1.86 .01 1.82 – 1.89 
AD 1.83 .02 1.79 – 1.88 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .01 .03 .56 .84 
SCD – AD .04 .03 1.38 .26 
MCI – AD .03 .03 1.12 .51 





Regression Models for the Volume of the Left Middle Occipital Gyrus 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -98.95* 49.21 -196.0 –
-1.9 
-70.74 49.52 -168.42 – 
26.93 
-44.75 51.17 -145.69 – 
56.19 
-50.46 52.33 -61.84 – 
97.49 
Sex  22.37 102.51 -179.96 
– 224.71 
74.66 105.30 -133.03 – 
282.35 
98.47 105.36 -109.35 – 
306.29 
108.21 108.65 -80.60 – 
250.22 
Education 47.12 49.32 -50.15 – 
144.38 
26.53 49.44 -70.98 – 
124.03 
32.21 49.15 -64.73 – 
129.14 
22.85 50.36 -22.23 – 
131.11 
ICV 65.98 51.00 -34.60 – 
166.55 
77.71 50.41 -21.72 – 
177.14 
83.07 50.11 -15.77 – 
181.91 




   -51.94 120.88 -290.35– 
186.46 
-48.57 120.21 -258.68 – 
188.54 




   -375.63* 150.54 -672.55 – 
-78.71 
-308.13* 155.89 -615.63 –   
-.64 
-345.43* 168.93 -492.25 – 
- 22.13 
RA       56.90 55.82 -114.33 – 
55.48 
60.48 127.97 -257.22 – 
132.43 
CS       132.08* 60.11 13.52 – 
250.64 
115.29 127.76 -231.18 – 
157.82 
Group x Vision            
MCI x RA         -37.8 151.81 -337.32 – 
261.71 
AD x RA         -6.24 182.08 -365.47 – 
352.98 
MCI x CS         12.98 151.36 -285.65 – 
311.61 




.01 .04 .06 .04 
AIC  3189.93 3185.87 3184.87 3195.78 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Middle Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 4333 99.1 4137 – 4528 
MCI 4281 67.6 4148 – 4414 
AD 3957 105.6 3749 – 4165 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 51.9 121 .43 .90 
SCD – AD 375.6 151 2.50 .04 
MCI – AD 323.7 125 2.59 .03 





Regression Models for the Thickness of the Left Middle Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .01 .01 -.02 – .03 .01 .01 -.01 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 
Sex  -.03 .02 -.08 – .01  -.02 .02 -.07 – .03 -.02 .03 -.07 – .03 -.03 .03 -0.08 – .03 
Education .02 .01 -.00 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 
ICV -.01 .01 -.04 – .01 -.01 .01 -.04 – .01  -.01 .01 -.04 – .01 -.01 .01 -.04 – .01 
Group 
(MCI) 
   -.02 .03 -.08 – .03 -.02 .03 -.08 – .03 -.03 .03  -.09 – .04 
Group 
(AD) 
   -.10** .04 -.17 – -.03 -.09* .04 -.16 – -.01 -.10* .04 -.18 – -.02 
RA       .00 .01 -.03 – .03 .05 .03 -.01 – .11 
CS       .01 .01 -.02 – .04 .04 .03 -.02 – .1 
Group x Vision            
MCI x RA         -.06 .04 -.13 – .01 
AD x RA         -.06 .04 -.14 – .03 
MCI x CS         -.02 .04 -.1 – .05 
AD x CS         -.05 .04 -.14 – .03 
Adjusted 
R2 
.02 .05 .05 .04 
AIC  -148.57 -152.88 -149.74 -140.67 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Middle Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.44 .02 2.4 – 2.49 
MCI 2.42 .02 2.39 – 2.45 
AD 2.35 .03 2.3 – 2.4 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .03 .87 .66 
SCD – AD .10 .04 2.71 .02 
MCI – AD .07 .03 2.42 .04 





Regression Models for the Volume of the Left Middle Occipital Lunatus Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -1.51 23.56 -47.98 – 
44.95 
6.52 24.03 -40.87 – 
53.91 
9.99 24.82 -38.96 – 
58.94 
9.12 25.05 -40.31 – 
58.54 
Sex  19.82 49.12 -77.06 –
116.69 
37.32 51.09 -63.44 – 
138.09 
51.46 51.09 -49.32 – 
152.23 
47.20 52.02 -55.42 – 
149.83 
Education 46.55 23.61 -.02 – 
93.12 
40.12 23.99 -7.18 – 
87.43 
42.06 23.83 -4.95 – 
89.06 
42.48 24.11 -5.09 – 
90.05 
ICV 70.01** 24.42 21.86 – 
118.17 
73.34** 24.46 25.10 – 
121.59 
75.77** 24.3 27.84 – 
123.70 




   -29.90 58.65 -145.57– 
85.77 
-33.91 58.29 -148.89 – 
81.07 




   -113.39 73.04 -257.45 – 
-30.67 
-113.02 75.60 -262.13 –   
-36.09 
-112.79 80.88 -272.35 – 
46.78 
RA       57.48* 27.07 4.09 – 
110.88 
-96.54 61.27 -24.33 – 
217.41 
CS       46.42 29.15 -11.07 – 
103.91 
-62.52 61.16 -58.16 – 
183.19 
Group x Vision            
MCI x RA         -23.19 72.68 -166.58 – 
120.21 
AD x RA         -161.87 87.17 -333.85 – 
10.11 
MCI x CS         -7.76 72.46 -150.73 – 
135.31 




.04 .05 .06 .07 
AIC  2895.33 2896.58 2895.37 2901.15 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Middle Occipital Lunatus Sulcus  
Group Estimated Marginal Mean SE 95% CI 
SCD 1312 48.1 1217 – 1407 
MCI 1282 32.8 1218 – 1347 
AD 1199 51.2 1098 – 1300 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 29.9 58.6 .51 .87 
SCD – AD 113.4 73 1.44 .27 
MCI – AD 83.5 60.7 1.38 .36 





Regression Models for the Thickness of the Left Middle Occipital Lunatus Sulcus  
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .02 .01 -.00 – .04 .03* .01 .00 – .05 .03* .01 .01 – .06 .03** .01 .01 – .06 
Sex  -.06* .02 -.11 – -.01  -.04 .03 -.09 – .01 -.04 .03 -.09 – .01 -.04 .03 -0.09 – .01 
Education .02* .01 .00 – .05 .02 .01 -.01 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 
ICV .01 .01 -.02 – .03 .01 .01 -.01 – .04  -.01 .01 -.01 – .04 .02 .01 -.01 – .04 
Group 
(MCI) 
   -.05 .03 -.1 – .01 -.04 .03 -.1 – .01 -.04 .03  -.1 – .02 
Group 
(AD) 
   -.12** .04 -.19 – -.05 -.11** .04 -.19 – -.04 -.13*** .04 -.21 – -.06 
RA       -.00 .01 -.03 – .03 .01 .03 -.05 – .07 
CS       .01 .01 -.02 – .04 .01 .03 -.05 – .07 
Group x Vision            
MCI x RA         -.02 .04 -.09 – .05 
AD x RA         -.05 .04 -.14 – .04 
MCI x CS         .03 .04 -.05 – .1 
AD x CS         -.02 .04 -.11 – .06 
Adjusted 
R2 
.05 .1 .09 .09 
AIC  -143.21 -151.57 -148.43 -142.4 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Middle Occipital Lunatus Sulcus  
Group Estimated Marginal Mean SE 95% CI 
SCD 2.02 .02 1.97 – 2.06 
MCI 1.97 .02 1.94 – 2 
AD 1.89 .03 1.84 – 1.94 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .05 .03 1.59 .25 
SCD – AD .12 .04 3.46 .00 
MCI – AD .08 .03 2.63 .03 





Regression Models for the Volume of the Left Superior Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -63.03* 27.78 -117.81 
– -8.25 
-58.56* 28.48 -114.73 – 
-2.39 
-49.48 29.62 -107.91 – 
8.95 
-51.57 25.05 -110.08 – 
6.94 
Sex  35.56 57.91 -78.65 –
149.76 
45.93 60.55 -73.51 – 
165.36 
56.16 60.99 -64.14 – 
176.47 
38.68 61.58 -82.8 – 
160.17 
Education 48.88 27.84 -6.02 – 
103.79 
45.17 28.43 -10.9 – 
101.24 
47.36 28.45 -8.76 – 
103.48 
57.1* 28.54 .79 – 
113.41 
ICV 18.85 28.78 -37.92 – 
75.52 
20.7 28.99 36.48 – 
77.87 
22.87 29.01 -34.45 – 
80.09 




   -20.27 69.51 -157.37– 
116.82 
-19.88 69.59 -157.14 – 
117.39 




   -64.63 86.57 -235.38 – 
106.11 
-42.57 90.25 -220.58 –   
135.44 
5.03 95.74 -183.87 – 
193.92 
RA       28.63 32.32 -35.12 – 
92.37 
123.13 72.53 -19.96 – 
266.22 
CS       51.19 34.8 -17.44 – 
119.82 
129.10 72.4 -13.75 – 
271.95 
Group x Vision            
MCI x RA         -123.91 86.04 -293.66 – 
45.84 
AD x RA         -83.92 103.19 -287.5 – 
119.67 
MCI x CS         -134.53 85.78 -303.78 – 
34.71 




.02 .02 .02 .04 
AIC  2961.15 2964.55 2966.22 2968.63 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Superior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2322 57.0 2209 – 2434 
MCI 2302 38.9 2225 – 2378 
AD 2257 60.7 2138– 2377 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 20.3 69.5 .29 .95 
SCD – AD 64.6 86.6 .75 .74 
MCI – AD 44.4 72 .62 .81 





Regression Models for the Thickness of the Left Superior Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.01 .01 -.04 – .01 -.01 .01 -.03 – .02 -.01 .01 -.04 – .01 -.01 .01 -.04 – .02 
Sex  -.06* .03 -.11 – -.01  -.05* .03 -.1 – -.00 -.06* .03 -.11 – -.00 -.07* .03 -0.12 – -.01 
Education .03* .01 .01 – .06 .03* .01 .00 – .05 .03* .01 .00 – .05 .03* .01 .00 – .05 
ICV -.01 .01 -.03 – .02 -.01 .01 -.03 – .02  -.01 .01 -.03 – .02 -.01 .01 -.03 – .02 
Group 
(MCI) 
   -.03 .03 -.09 – .03 -.03 .03 -.09 – .03 -.03 .03  -.09 – .04 
Group 
(AD) 
   -.06 .04 -.13 – .02 -.06 .04 -.14 – .02 -.08* .04 -.17 – -.00 
RA       -.01 .01 -.04 – .02 .02 .03 -.05 – .08 
CS       -.01 .02 -.04 – .02 .00 .03 -.06 – .07 
Group x 
Vision 
            
MCI x RA          -.06 .04 -.14 – .01 
AD x RA          -.01 .05 -.1 – .08 
MCI x CS          -.01 .04 -.08 – .07 
AD x CS          -.04 .04 -.13 – .04 
Adjusted 
R2 
.07 .07 .06 .08 
AIC  -132.18 -130.41 -127.56 -124.22 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Superior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.12 .02 2.07 – 2.17 
MCI 2.09 .02 2.06 – 2.12 
AD 2.06 .03 2.01 – 2.12 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .03 .03 .96 .60 
SCD – AD .06 .04 1.47 .31 
MCI – AD .03 .03 .84 .68 





Regression Models for the Volume of the Left Occipital Pole 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -10.67 31.05 -71.91 – 
50.57 
1.42 31.51 -60.74 – 
63.57 
8.89 29.62 -55.42 – 
73.2 
10.56 33.47 -55.47 – 
76.59 
Sex  -49.00 64.74 -176.67 
–78.67 
-10.00 67.01 -142.16 – 
122.17 
7.54 67.12 -124.85 – 
139.94 
-.44 69.49 -137.54 – 
136.65 
Education 47.38 31.12 -13.99 – 
108.76 
34.96 31.46 -27.08 – 
97.01 
37.74 31.31 -24.02 – 
99.5 
43.17 32.21 -20.38 – 
106.72 
ICV 96.82** 32.18 33.36 – 
160.28 
101.79** 32.08 38.52 – 
165.06 
105** 31.92 -42.03 – 
167.97 




   -117.90 76.92 -269.62– 
33.81 
-121.29 76.58 -272.34 – 
29.77 




   -201.96* 95.8 -390.31 – 
-13.01 
-190.99 99.32 -386.89 –   
4.9 
-210.25 108.05 -423.42 – 
2.92 
RA       65.05 35.56 -5.10 – 
135.2 
74.07 81.85 -87.44 – 
235.51 
CS       66.07 38.29 -9.46 – 
141.60 
62.97 81.71 -98.24 – 
224.18 
Group x Vision            
MCI x RA         -17.13 97.09 -208.69 – 
174.43 
AD x RA         6.26 116.45 -223.49 – 
236.01 
MCI x CS         10.77 96.81 -180.23 – 
201.77 




.04 .05 .06 .03 
AIC  3005.75 3005.07 3004.52 3017 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Occipital Pole 
Group Estimated Marginal Mean SE 95% CI 
SCD 2984 63.1 2859 – 3108 
MCI 2866 43.0 2781 – 2951 
AD 2782 67.2 2649– 2914 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 117.9 76.9 1.53 .28 
SCD – AD 202.0 95.8 2.11 .01 
MCI – AD 84.1 79.6 1.06 .54 





Regression Models for the Thickness of the Left Occipital Pole 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .00 .01 -.02 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
Sex  -.06** .02 -.11 – -.02  -.05 .02 -.09 – .00 -.04 .02 -.09 – .00 -.05 .02 -0.09 – .00 
Education .02* .01 .00 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 .02 .01 -.00 – .04 
ICV .00 .01 -.02 – .03 .01 .01 -.02 – .03  .01 .01 -.02 – .03 .01 .01 -.02 – .03 
Group 
(MCI) 
   -.06* .03 -.11 – -.01 -.06* .03 -.11 – -.01 -.07* .03  -.13 – -.01 
Group 
(AD) 
   -.09** .03 -.16 – -.03 -.09* .04 -.16 – -.02 -.12** .04 -.19 – -.04 
RA       .00 .01 -.02 – .03 .01 .03 -.05 – .06 
CS       .01 .01 -.02 – .04 .01 .03 -.05 – .07 
Group x Vision            
MCI x RA         -.01 .03 -.08 – .05 
AD x RA         -.01 .04 -.09 – .07 
MCI x CS         .01 .03 -.06 – .08 
AD x CS         -.01 .04 -.09 – .07 
Adjusted 
R2 
.04 .07 .07 .06 
AIC  -168.42 -172.65 -169.15 -160.73 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Occipital Pole 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.02 .02 1.97 – 2.06 
MCI 1.96 .02 1.93 – 1.99 
AD 1.93 .02 1.88 – 1.97 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .06 .03 2.20 .07 
SCD – AD .09 .03 2.76 .02 
MCI – AD .03 .03 1.19 .46 





Regression Models for the Volume of the Left Calcarine Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -3.29 40.90 -83.95 – 
77.37 
11.83 41.52 -70.06 – 
93.72 
5.37 43.41 -80.25 – 
90.99 
7.26 44.14 -55.47 – 
76.59 
Sex  115.08 85.27 -53.08 –
283.25 
166.66 88.28 -7.46 – 
340.79 
162.91 89.37 -13.37 – 
339.2 
180.44 91.64 -137.54 – 
136.65 
Education 82.59* 40.99 1.75 – 
163.43 
66.45 41.45 -15.30 – 
148.19 
65.27 41.69 -16.96 – 
147.49 
56.7 42.48 -20.38 – 
106.72 
ICV 28.41 42.38 -55.18 – 
112 
34.62 42.27 -48.74 – 
117.98 
33.62 42.51 -50.22 – 
117.47 




   -163.48 101.34 -363.36– 
36.39 
-165.2 101.97 -366.33 – 
35.92 




   -259.6* 126.21 -508.54 – 
-10.66 
-278.09* 132.24 -538.92 –   
-17.26 
-213.83 142.49 -423.42 – 
2.92 
RA       -4.26 47.35 -97.66 – 
89.14 
-37.22 107.94 -87.44 – 
235.51 
CS       -27.13 50.99 -127.7 – 
73.44 
-70.82 107.76 -98.24 – 
224.18 
Group x Vision            
MCI x RA         100.15 128.05 -208.69 – 
174.43 
AD x RA         -27.67 153.57 -223.49 – 
236.01 
MCI x CS         41.88 127.67 -180.23 – 
201.77 




.01 .02 .02 .00 
AIC  3115.94 3115.36 3119.04 3127.68 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Calcarine Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 3058 83.1 2894 – 3222 
MCI 2894 56.7 2783 – 3006 
AD 2798 88.5 2623– 2973 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 163.5 101 1.61 .24 
SCD – AD 259.6 126 2.06 .10 
MCI – AD 96.1 105 .92 .63 





Regression Models for the Thickness of the Left Calcarine Sulcus 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.00 .01 -.02 – .01 .00 .01 -.02 – .02 .00 .01 -.02 – .02 .00 .01 -.02 – .02 
Sex  -.02 .02 -.05 – .02  -.00 .02 -.04 – .04 -.00 .02 -.04 – .04 -.00 .02 -.04 – .04 
Education .02* .01 .00 – .04 .01 .01 -.00 – .03 .02 .01 -.00 – .03 .02 .01 -.00 – .04 
ICV -.00 .01 -.02 – .01 -.00 .01 -.02 – .02  -.00 .01 -.02 – .02 -.00 .01 -.02 – .02 
Group 
(MCI) 
   -.05* .02 -.09 – -.00 -.04 .02 -.09 – .00 -.05 .03  -.1 – .00 
Group 
(AD) 
   -.07* .03 -.12 – -.01 -.06* .03 -.12 – -.00 -.06* .03 -.13 – -.00 
RA       -.00 .01 -.02 – .02 .01 .02 -.04 – .06 
CS       .01 .01 -.02 – .03 .02 .02 -.03 – .07 
Group x Vision            
MCI x RA         -.02 .03 -.07 – .04 
AD x RA         -.03 .03 -.10 – .04 
MCI x CS         -.02 .03 -.08 – .04 
AD x CS         .00 .03 -.07 – .07 
Adjusted 
R2 
.01 .03 .03 .00 
AIC  -244.76 -247.36 -243.91 -233.03 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Calcarine Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 1.86 .02 1.82 – 1.9 
MCI 1.81 .01 1.79 – 1.84 
AD 1.79 .02 1.75 – 1.83 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .05 .02 2.02 .11 
SCD – AD .07 .03 2.44 .04 
MCI – AD .02 .02 .99 .58 





Regression Models for the Volume of the Left Anterior Occipital Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .49 20.84 -40.61 – 
41.58 
4.48 21.35 -37.63 – 
46.59 
5.89 22.31 -38.12 – 
49.9 
6.18 22.74 -38.67 – 
51.04 
Sex  75.69 43.44 -9.99 –
161.37 
84.91 45.4 -4.64 – 
174.45 
81.82 45.94 -8.78 – 
172.43 
71.93 47.21 -21.21 – 
165.06 
Education 19.91 20.88 -21.27 – 
61.1 
16.61 21.31 -25.43 – 
58.64 
16.45 21.43 -25.82 – 
58.71 
14.44 21.88 -28.73 – 
57.61 
ICV 17.39 21.59 -25.2 – 
59.98 
19.04 21.73 -23.83 – 
61.91 
18.65 21.85 -24.45 – 
61.74 




   -17.84 52.11 -120.63– 
84.94 
-15.88 52.41 -119.25 – 
87.5 




   -57.62 64.9 -185.63 – 
70.39 
-50.49 67.97 -184.55 –   
83.57 
-74.42 73.4 -219.23 – 
70.39 
RA       -16.84 24.34 -64.85 – 
31.17 
47.97 55.6 -61.73 – 
157.66 
CS       -4.32 26.21 -56.01 – 
47.37 
4.19 55.51 -105.33 – 
113.7 
Group x Vision            
MCI x RA         -98.29 65.96 -228.42 – 
31.84 
AD x RA         -77.16 79.11 -223.24 – 
78.91 
MCI x CS         -1.00 65.76 -130.74 – 
128.75 




.01 .00 -.01 -.02 
AIC  2846.2 2849.34 2852.81 2682.33 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Anterior Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 973 42.7 889 – 1057 
MCI 955 29.2 898 – 1013 
AD 915 45.5 836 – 1005 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 17.8 52.1 .34 .94 
SCD – AD 57.6 64.9 .89 .65 
MCI – AD 39.8 53.9 .74 .74 





Regression Models for the Thickness of the Left Anterior Occipital Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.00 .01 -.02 – .02 .01 .01 -.01 – .03 .01 .01 -.01 – .04 .02 .01 -.01 – .04 
Sex  -.03 .02 -.07 – .02  -.00 .02 -.05 – .05 -.00 .02 -.05 – .04 -.00 .02 -.05 – .05 
Education .02 .01 .00 – .04 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
ICV -.01 .01 -.03 – .01 -.01 .01 -.03 – .02  -.01 .01 -.03 – .02 -.01 .01 -.03 – .02 
Group 
(MCI) 
   -.05 .03 -.11– .00 -.05 .03 -.1 – .00 -.05 .03  -.11 – .01 
Group 
(AD) 
   -.14*** .03 -.21 – -.08 -.13*** .04 -.2 – -.06 -.14*** .04 -.21 – -.06 
RA       -.02 .01 -.04 – .01 -.03 .03 -.09 – .03 
CS       .01 .01 -.02 – .03 -.04 .03 -.1 – .02 
Group x Vision           
MCI x RA         .02 .03 -.04 – .09 
AD x RA         .01 .04 -.17 – .09 
MCI x CS         .07* .03 .01 – .14 
AD x CS         .03 .04 -.05 – .11 
Adjusted 
R2 
.01 .03 .03 .00 
AIC  -244.76 -247.36 -243.91 -233.03 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Anterior Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.22 .02 2.17 – 2.26 
MCI 2.16 .02 2.13 – 2.2 
AD 2.07 .02 2.03 – 2.12 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .05 .03 1.92 .14 
SCD – AD .14 .03 4.17 .00 
MCI – AD .09 .03 3.16 .01 





Regression Models for the Volume of the Left Parieto-Occipital Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -4.75 36.41 -76.56 – 
67.06 
24.88 35.88 -45.89 – 
95.65 
29.93 37.5 -44.03 – 
103.9 
32.34 38.15 -42.93 – 
107.62 
Sex  91.73 75.91 -57.98 –
241.44 
162.37* 76.3 11.88 – 
312.85 
159.75* 77.2 7.47 – 
312.03 
146.59 79.22 -9.71 – 
302.88 
Education 63.51 36.49 -8.45 – 
135.48 
38.48 35.82 -32.16 – 
109.13 
38.81 36.01 -32.22 – 
109.84 




37.73 25.83 – 
174.66 
112.51** 36.53 40.47 – 
184.55 








   -145.13 87.58 -317.87– 
27.6 
-141.53 88.08 -315.27 – 
32.21 




   -433.34*** 109.08 -648.47 – 
-218.21 




123.17 -617.91 – 
-131.89 
RA       -21.93 40.9 -102.61 – 
58.75 
68.77 93.31 -115.32 – 
252.85 
CS       6.65 44.04 -80.22 – 
93.53 
-53.24 93.15 -237.02 – 
130.54 
Group x Vision            
MCI x RA         -115.05 110.69 -333.43 – 
103.22 
AD x RA         -62.47 132.75 -324.38 – 
199.45 
MCI x CS         41.4 110.36 -176.34 – 
259.13 




.05 .11 .11 .09 
AIC  3069.43 3056.98 3060.49 3069.41 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Left Parieto-Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2934 71.8 2793 – 3076 
MCI 2789 49.0 2693 – 2886 
AD 2501 76.5 2350– 2652 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 145 87.6 1.66 .22 
SCD – AD 433 109.1 3.97 .00 
MCI – AD 288 90.7 3.18 .00 





Regression Models for the Thickness of the Left Parieto-Occipital Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.01 .01 -.03 – .02 .00 .01 -.02 – .02 .00 .01 -.02 – .03 .00 .01 -.02 – .03 
Sex  -.03 .02 -.07 – .02  -.02 .02 -.06 – .03 -.02 .02 -.06 – .03 -.02 .02 -.07 – .03 
Education .02 .01 -.00 – .04 .02 .01 -.01 – .04 .02 .01 -.01 – .04 .02 .01 -.00 – .04 
ICV -.01 .01 -.03 – .01 -.01 .01 -.03 – .02  -.01 .01 -.03 – .02 -.01 .01 -.03 – .02 
Group 
(MCI) 
   -.00 .03 -.06 – .05 -.00 .03 -.06 – .05 -.02 .03  -.08 – .04 
Group 
(AD) 
   -.09** .03 -.15 – -.02 -.08* .03 -.15 – -.01 -.09* .04 -.16 – -.02 
RA       -.01 .01 -.03 – .02 -.00 .03 -.06 – .05 
CS       .00 .01 -.02 – .03 -.01 .03 -.07 – .04 
Group x Vision            
MCI x RA         -.00 .03 -.07 – .07 
AD x RA         -.02 .04 -.1 – .06 
MCI x CS         .03 .03 -.04 – .09 
AD x CS         .01 .04 -.06 – .09 
Adjusted 
R2 
.02 .06 .05 .02 
AIC  -176.99 -182.99 -179.81 -167.29 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Left Parieto-Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.14 .02 2.09 – 2.18 
MCI 2.13 .01 2.1– 2.16 
AD 2.05 .02 2 – 2.09 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .00 .03 .19 .98 
SCD – AD .09 .03 2.64 .02 
MCI – AD .08 .03 2.99 .01 





Regression Models for the Volume of the Right Inferior Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -10.93 36.43 -82.78 – 
60.91 
1.06 37.03 -71.98 – 
74.10 
13.82 38.36 -61.84 – 
89.49 
12.97 38.98 -63.94 – 
89.88 
Sex  115.51 75.95 -34.27 –
265.29 
123.29* 78.74 -32.01 – 
278.59 
141.97 78.97 -13.8 – 
297.75 
127.29 80.93 -32.39 – 
286.97 
Education 92.3* 36.51 20.29 – 
164.30 
86.68* 36.97 13.77 – 
159.19 
90.21* 36.84 17.55 – 
162.88 
92.62* 37.51 18.6 – 
166.63 
ICV 66.48 37.75 -7.97 – 
140.94 
71.52 37.70 -2.83 – 
145.87 
75.25* 37.56 1.16 – 
149.34 




   61.14 90.38 -117.13– 
239.41 
59.95* 90.11 -117.78 – 
237.68 




   -123.97 112.57 -345.99 – 
98.05 
-96.35 116.85 -326.84 –   
134.14 
-129.09 125.84 -377.37 – 
119.19 
RA       59.78 41.84 -22.76 – 
142.31 
145.68 95.33 -42.39 – 
333.76 
CS       83.23 45.05 -5.64 – 
172.09 
234.01* 95.17 46.25– 
421.77 
Group x Vision            
MCI x RA         -98.66 113.09 -321.78 – 
124.45 
AD x RA         -178.92 135.63 -446.51 – 
88.67 
MCI x CS         -158.43 112.75 -380.88 – 
64.02 




.04 .05 .06 .05 
AIC  3069.64 3069.59 3069.57 3077.99 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Inferior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2390 74.1 2244 – 2537 
MCI 2452 50.6 2352 – 2551 
AD 2266 78.9 2111 – 2422 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 90.4 90.4 -.68 .78 
SCD – AD 124 112.6 1.1 .51 
MCI – AD 158.1 93.6 1.98 .12 





Regression Models for the Thickness of the Right Inferior Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -.01 .01 -.04 – .02 -.01 .02 -.04 – .02 .00 .02 -.03 – .03 .00 .02 -.03 – .03 
Sex  .01 .03 -.05 – .08  .02 .03 -.05 – .08 .02 .03 -.05 – .08 .02 .03 -.05 – .08 
Education .05 
*** 
.01 .02 – .08 .05** .02 .02 – .08 .05** .02 .02 – .08 .05** .02 .02 – .08 
ICV -.02 .02 -.05 – .01 -.02 .02 -.05 – .01  -.02 .02 -.05 – .01 -.01 .02 -.05 – .02 
Group 
(MCI) 
   .01 .04 -.06 – .09 .02 .04 -.06 – .09 .03 .04  -.05 – .12 
Group 
(AD) 
   -.03 .05 -.12 – .06 -.01 .05 -.11 – .08 -.01 .05 -.11 – .09 
RA       -.01 .02 -.04 – .02 -.01 .04 -.09 – .07 
CS       .01 .02 -.02 – .05 .03 .04 -.05 – .1 
Group x Vision            
MCI x RA         .01 .05 -.08 – .1 
AD x RA         -.01 .06 -.13 – .1 
MCI x CS         -.01 .05 -.10 – .09 
AD x CS         -.03 .06 -.14 – .08 
Adjusted 
R2 
.04 .04 .04 .01 
AIC  -53.21 -50.53 -48.2 -35.85 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Inferior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.44 .03 2.38 – 2.5 
MCI 2.45 .02 2.41– 2.49 
AD 2.41 .03 2.35 – 2.47 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -.01 .04 -.38 .92 
SCD – AD .03 .05 .63 .8 
MCI – AD .04 .04 1.13 .5 





Regression Models for the Volume of the Right Cuneus 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -35 41.39 -116.63 
– 46.33 
-10.91 41.64 -93.03 – 
71.22 
-5.33 43.53 -91.19 – 
80.54 
-1.36 44.55 -89.25 – 
86.53 
Sex  97.39 86.29 -72.79 –
267.57 
145.02 88.54 -29.61 – 
319.65 
143.33 89.62 -33.45 – 
320.11 




41.48 40.37 – 
203.99 
103.95* 41.57 21.97 – 
185.94 
104.45* 41.81 21.99 – 
186.9 
97.78* 42.87 13.19 – 
182.36 
ICV 83.71 42.87 -.88 – 
168.31 
93.72* 42.39 10.12 – 
177.33 
93.81* 42.63 9.73 – 
177.89 




   -61.48 101.63 -261.94– 
138.97 
-57.99 102.26 -259.69 – 
143.71 




   -328.15* 126.58 -577.81 – 
-78.49 




143.81 -610.77 – 
-43.31 
RA       -18.74 47.49 -112.4 – 
74.93 
-103.17 108.94 -318.11 – 
111.76 
CS       10.5 51.13 -90.35 – 
111.35 
-80.99 108.76 -295.56 – 
133.59 
Group x Vision            
MCI x RA         110.35 129.24 -144.62 – 
365.33 
AD x RA         110.62 155 -195.18 – 
416.43 
MCI x CS         141.84 128.85 -112.38 – 
396.06 




.05 .08 .07 .05 
AIC  3120.71 3116.52 3120.17 3131.38 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Cuneus 
Group Estimated Marginal Mean SE 95% CI 
SCD 3161 83.3 2997 – 3326 
MCI 3100 56.9 2988 – 3212 
AD 2833 88.8 2658 – 3008 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 61.5 102 .61 .81 
SCD – AD 328.2 127 2.59 .03 
MCI – AD 266.7 105 2.54 .03 





Regression Models for the Thickness of the Right Cuneus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .01 .01 -.00 – .03 .02 .01 -.00 – .04 .02 .01 -.00 – .04 .02 .01 -.00 – .04 
Sex  -.03 .02 -.07 – .01  -.02 .02 -.06 – .02 -.03 .02 -.07 – .01 -.02 .02 -.06 – .02 
Education .01 .01 -.01 – .03 .01 .01 .01– .02 .01 .01 -.01 – .02 .00 .01 -.02 – .02 
ICV -.00 .01 -.02 – .02 .00 .01 -.02 – .02  -.00 .01 -.02 – .02 -.00 .01 -.02 – .02 
Group 
(MCI) 
   -.01 .02 -.06 – .03 -.01 .02 -.06 – .04 -.01 .03  -.06 – .04 
Group 
(AD) 
   -.06 .03 -.11 – .00 -.06 .03 -.12 – .00 -.06 .03 -.12 – .01 
RA       -.02 .01 -.04 – .00 -.05* .02 -.1 – -.00 
CS       -.02 .01 -.04 – .00 -.05 .02 -.1 – .00 
Group x Vision            
MCI x RA         .04 .03 -.02 – .1 
AD x RA         .04 .04 -.03 – .11 
MCI x CS         .03 .03 -.02 – .09 
AD x CS         .03 .03 -.04 – .1 
Adjusted 
R2 
.01 .02 .03 .02 
AIC  -233.18 -233.49 -234.21 -224.35 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Cuneus 
Group Estimated Marginal Mean SE 95% CI 
SCD 1.9 .02 1.87 – 1.94 
MCI 1.89 .01 1.87 – 1.92 
AD 1.85 .02 1.81 – 1.89 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .01 .02 .5 .87 
SCD – AD .06 .03 1.9 .14 
MCI – AD .04 .02 1.8 .17 





Regression Models for the Volume of the Right Middle Occipital Gyrus 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -61.04 53.23 -166.02 
– 43.94 
-30.27 53.4 -135.6 – 
75.06 
-21.41 55.78 -131.44 – 
88.63 






260.96* 113.55 36.99 – 
484.93 
271.54* 114.85 45 – 
498.08 
250.08* 53.5 22.35 – 
477.82 
Education 92.56 53.35 -12.66 – 
197.78 
733.4 53.31 -31.75 – 
178.54 
75.6 53.57 -30.07 – 
181.27 




55.16 5.55 – 
223.15 
127.2* 54.36 19.98 – 
234.42 
129.41* 54.62 21.67 – 
237.16 




   30.81 130.35 -226.28– 
287.9 
30.96 131.04 -227.51 – 
289.43 




   -372.13* 162.34 -692.32 – 
-51.93 




143.81 -675.74 – 
32.45 
RA       30.6 60.85 -89.43 – 
150.63 
244.88 135.96 -23.35 – 
513.11 
CS       51.51 65.52 -77.73 – 
180.75 
-43.48 135.73 -311.27 – 
224.3 
Group x Vision            
MCI x RA         -379.85 
* 
161.28 -698.05 – 
-61.64 
AD x RA         -93.15 193.44 -474.79 – 
288.49 
MCI x CS         30.38 160.81 -286.88 – 
347.65 




.05 .08 .08 .1 
AIC  3221.36 3216.05 3219.37 3219.99 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Middle Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 4567 106.9 4356 – 4778 
MCI 4598 72.9 4454 – 4742 
AD 4195 113.8 3970 – 4419 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -30.8 130 -.24 .97 
SCD – AD 372.1 162 2.29 .06 
MCI – AD 402.9 135 2.97 .01 





Regression Models for the Thickness of the Right Middle Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .01 .01 -.01 – .04 .02 .01 -.00 – .04 .02 .01 -.00 – .05 .02 .01 -.00 – .05 
Sex  -.03 .03 -.08 – .02  -.01 .03 -.07 – .04 -.02 .03 -.07 – .04 -.02 .03 -.07 – .03 
Education .01 .01 -.01 – .03 .01 .01 .02 – .03 .01 .01 -.02 – .03 .01 .01 -.02 – .03 
ICV -.00 .01 -.03 – .02 .00 .01 -.02 – .03 .00 .01 -.02 – .03 .00 .01 -.02 – .03 
Group 
(MCI) 
   -.02 .03 -.08 – .04 -.01 .03 -.07 – .04 -.01 .03  -.08 – .05 
Group 
(AD) 
   -.08* .04 -.15 – -.00 -.06 .04 -.14 – .01 -.07 .04 -.15 – .02 
RA       -.02 .01 -.04 – .01 .01 .03 -.05 – .08 
CS       .00 .02 -.03 – .03 .01 .03 -.06 – .07 
Group x Vision            
MCI x RA         -.04 .04 -.12 – .03 
AD x RA         -.04 .05 -.13 – .05 
MCI x CS         -.01 .04 -.09 – .06 
AD x CS         .02 .05 -.07 – .11 
Adjusted 
R2 
-.00 .01 .01 -.02 
AIC  -133.09 -133.88 -131.76 -120.36 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Middle Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.48 .02 2.43 – 2.52 
MCI 2.46 .02 2.43 – 2.49 
AD 2.4 .03 2.35 – 2.45 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .03 .57 .87 
SCD – AD .08 .04 2.02 .11 
MCI – AD .06 .03 1.88 .15 






Regression Models for the Volume of the Right Middle Lunatus Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -14.82 22.55 -59.3 – 
29.66 
-9.2 23.07 -54.71 – 
36.3 
-9.2 24.09 -56.72 – 
38.32 






137.78** 49.06 41.02 – 
234.55 




50.57 50.16 – 
249.71 
Education 38.79 22.6 -5.78 – 
83.37 
34.52 23.03 -10.91 – 
79.95 
35.08 23.14 -10.55 – 
80.71 
34.68 23.44 -11.57 – 
80.92 
ICV 16.2 23.37 -29.89 – 
62.29 
18.53 23.49 -27.79 – 
64.86 
19.35 23.59 -27.18 – 
65.88 




   -14.95 56.32 -126.02 – 
96.13 
-17.06 56.59 -128.68 – 
94.56 




   -76.76 70.14 -215.1 –
61.58 




78.63 -187.95 – 
122.32 
RA       23.68 26.28 -28.15 – 
75.52 
17.18 59.56 -100.33 – 
134.7 
CS       28.3 28.3 -42.13 – 
69.49 
56.47 59.46 -60.85 – 
173.79 
Group x Vision            
MCI x RA         26.81 70.66 -102.6 – 
176.22 
AD x RA         -58.88 84.75 -226.08 – 
108.32 
MCI x CS         -69.95 70.45 -208.65 – 
69.35 




.04 .03 .03 .03 
AIC  2877.83 2880.36 2883.5 2889.88 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Middle Lunatus Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 1199 46.2 1108 – 1290 
MCI 1184 31.5 1122 – 1247 
AD 1123 49.2 1026 – 1220 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 14.9 56.3 .27 .96 
SCD – AD 76.8 70.1 1.10 .52 
MCI – AD 61.8 58.3 1.06 .54 





Regression Models for the Thickness of the Right Middle Lunatus Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .02 .01 -.01 – .04 .03* .01 .00 – .05 .03* .01 .00 – .05 .03* .01 .00 – .06 
Sex  .01 .03 -.05 – .05  .03 .03 -.03 – .08 .02 .03 -.03 – .08 .02 .03 -.04 – .07 
Education .02 .01 -.01 – .04 .01 .01 -.02 – .03 .01 .01 -.02 – .03 .01 .01 -.02 – .03 
ICV -.02 .01 -.05 – .01 -.02 .01 -.04 – .01 -.02 .01 -.04 – .1 -.01 .01 -.04 – .02 
Group 
(MCI) 
   -.03 .03 -.09 – .03 -.03 .03 -.09 – .03 -.02 .03  -.09 – .04 
Group 
(AD) 
   -.13*** .04 -.2 – -.05 -.13** .04 -.21 – -.05 -.13** .04 -.22 – -.05 
RA       -.02 .01 -.05 – .01 -.00 .03 -.07 – .06 
CS       -.01 .02 -.04 – .02 .00 .03 -.06 – .07 
Group x Vision            
MCI x RA         -.01 .04 -.08 – .07 
AD x RA         -.06 .05 -.15 – .03 
MCI x CS         -.00 .04 -.08 – .07 
AD x CS         -.04 .05 -.13 – .05 
Adjusted 
R2 
.01 .06 .06 .04 
AIC  -113.85 -122.78 -120.6 -110.14 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Middle Lunatus Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.07 .03 2.02 – 2.12 
MCI 2.04 .02 2.01 – 2.07 
AD 1.94 .03 1.89 – 1.99 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .03 .03 .95 .61 
SCD – AD .13 .04 3.35 .00 
MCI – AD .10 .03 3.11 .01 





Regression Models for the Volume of the Right Superior Occipital Gyrus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -44.94 34.2 -112.38 
– 22.5 
-32.43 34.72 -100.9 – 
36.04 
-32.65 36.32 -104.3 – 
39 
-33.86 36.54 -105.94 – 
38.23 
Sex  67.36 71.29 -73.25 –
207.96 
110.53 73.82 -35.06 – 
256.13 
111.71 74.78 -35.79 – 
259.22 
80.65 75.86 -69.02 – 
230.32 
Education 71.29* 34.27 3.7 – 
138.88 
57.83 34.66 -10.52 – 
126.18 
57.93 34.88 -10.88 – 
126.73 
67.58 35.16 -1.8 – 
136.95 
ICV 16.96 35.44 -52.94 – 
86.65 
22.09 35.34 -47.61 – 
91.79 
22.26 35.57 -47.9 – 
92.42 




   -138.19 84.74 -305.32 – 
28.94 
-138.78 85.32 -307.08 – 
29.52 




   -215.99* 105.53 -424.13 – 
-7.84 




117.95 -432.72 – 
32.7 
RA       5.82 39.62 -72.34 – 
83.97 
199.45* 89.35 23.17 – 
375.73 
CS       2.5 42.66 -81.65 – 
86.66 
91.72 89.2 -84.27 – 
267.71 
Group x Vision            
MCI x RA         -250.43 
* 
106 -459.55 –  
-41.31 
AD x RA         -227.02 127.13 -477.84 – 
23.79 
MCI x CS         -144.54 105.68 -353.05 – 
63.96 




.01 .03 .02 .03 
AIC  3044.34 3043.78 3047.76 3052.08 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Superior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2834 69.5 2697 – 2971 
MCI 2696 47.4 2602 – 2789 
AD 2618 74.0 2472 – 2764 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 138.2 84.7 1.63 .23 
SCD – AD 216 105.5 2.05 .10 
MCI – AD 77.8 87.7 .89 .65 





Regression Models for the Thickness of the Right Superior Occipital Gyrus 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .01 .01 -.01 – .03 .01 .01 -.01 – .04 .01 .01 -.01 – .04 .01 .01 -.01 – .04 
Sex  -.04 .02 -.09 – .00  -.03 .02 -.08 – .02 -.03 .02 -.08 – .02 -.03 .02 -.08 – .01 
Education .03** .01 .01 – .05 .03* .01 .00 – .05 .03* .01 .00 – .05 .02* .01 .00 – .05 
ICV -.01 .01 -.03 – .01 -.01 .01 -.03 – .02 -.01 .01 -.03 – .02 -.01 .01 -.03 – .02 
Group 
(MCI) 
   -.02 .03 -.08 – .03 -.02 .03 -.08 – .03 -.02 .03  -.08 – .04 
Group 
(AD) 
   -.08* .03 -.15 – -.02 -.08* .04 -.15 – -.01 -.09* .04 -.17 – -.02 
RA       -.01 .01 -.04 – .01 .01 .03 -.04 – .07 
CS       -.01 .01 -.03 – .02 .01 .03 -.04 – .07 
Group x Vision            
MCI x RA         -.05 .03 -.12 – .02 
AD x RA         -.03 .04 -.11 – .05 
MCI x CS         -.03 .03 -.09 – .04 
AD x CS         -.02 .04 -.1 – .06 
Adjusted 
R2 
.05 .07 .07 .07 
AIC  -174.41 -177.1 -174.26 -167.15 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Superior Occipital Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.18 .02 2.13 – 2.22 
MCI 2.15 .02 2.12 – 2.18 
AD 2.09 .02 2.05 – 2.14 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .03 .92 .63 
SCD – AD .08 .03 2.47 .04 
MCI – AD .06 .03 2.09 .10 





Regression Models for the Volume of the Right Occipital Pole 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age 1.39 49.98 -97.18 – 
99.95 
43.85 48.84 -52.49 – 
140.19 
66.31 50.54 -33.37 – 
166 
73.3 51.78 -28.87 – 
175.46 
Sex  66.36 104.19 -139.13 
– 271.84 
129.91 103.86 -74.94 – 
334.76 
153.61 104.05 -51.63 – 
358.86 
143.35 107.52 -68.77 – 
355.48 
Education 94.82 50.09 -3.96 – 
193.6 
67.11 48.76 -29.05 – 
163.28 
72.36 48.54 -23.38 – 
168.09 
81.15 49.84 -17.18 – 
179.47 
ICV 96.39 51.79 -5.76 – 
198.53 
114.1* 49.72 16.03 – 
212.17 
119.22* 49.49 21.61 – 
216.84 




   9.08 119.22 -226.06 – 
244.22 
10.72 118.72 -223.45– 
244.89 




   -527.96*** 148.48 -820.82 – 
-235.10 




167.17 -802.64 – 
-142.99 
RA       63.43 55.13 -45.32 – 
172.17 
58.67 126.64 -191.18 – 
308.51 
CS       122.35* 59.36 5.27 – 
239.44 
123.62 126.43 -125.81 – 
373.05 
Group x Vision            
MCI x RA         34.95 
 
150.23 -261.45 –  
331.34 
AD x RA         14.88 180.18 -340.61 – 
370.36 
MCI x CS         18 149.79 -277.52 – 
313.51 




.02 .1 .11 .09 
AIC  3196.11 3180.35 3179.88 3191.59 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Occipital Pole 
Group Estimated Marginal Mean SE 95% CI 
SCD 4759 97.8 4566 – 4952 
MCI 4768 66.7 4636 – 4900 
AD 4231 104.1 4026 – 4436 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -9.08 119 -.08 .97 
SCD – AD 527.96 148 3.56 .00 
MCI – AD 537.04 123 4.35 .00 





Regression Models for the Thickness of the Right Occipital Pole 
Variable 
Model 1 Model 2* Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .01 .01 -.01 – .02 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
Sex  -.04 .02 -.08 – .00  -.03 .02 -.07 – .01 -.03 .02 -.07 – .01 -.03 .02 -.07 – .02 
Education .02 .01 -.00 – .04 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
ICV -.00 .01 -.02 – .02 .00 .01 -.02 – .02 .00 .01 -.02 – .02 .00 .01 -.02 – .02 
Group 
(MCI) 
   -.02 .02 -.06 – .03 -.01 .02 -.06 – .03 -.02 .03  -.08 – .03 
Group 
(AD) 
   -.08* .03 -.14 – -.02 -.07* .03 -.13 – -.01 -.08* .03 -.14 – -.01 
RA       -.01 .01 -.03 – .01 -.01 .03 -.06 – .04 
CS       .01 .01 -.02 – .03 -.01 .03 -.06 – .04 
Group x Vision            
MCI x RA         -.00 .03 -.06 – .06 
AD x RA         .00 .04 -.07 – .08 
MCI x CS         .02 .03 -.05 – .08 
AD x CS         .02 .04 -.05 – .09 
Adjusted 
R2 
.02 .05 .05 .01 
AIC  -215.31 -219.27 -216.77 -203.78 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Occipital Pole 
Group Estimated Marginal Mean SE 95% CI 
SCD 2 .02 1.96 – 2.04 
MCI 1.99 .01 1.96 – 2.01 
AD 1.93 .02 1.88 – 1.97 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .02 .68 .78 
SCD – AD .08 .03 2.59 .03 
MCI – AD .06 .03 2.46 .04 





Regression Models for the Volume of the Right Calcarine Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -12.21 43.48 -97.95 – 
73.54 
1.79 44.36 -85.71 – 
89.29 
-11.29 46.2 -102.42 – 
79.83 
-14.62 46.79 -106.93 – 
77.69 
Sex  112.68 90.64 -66.08 – 
291.44 
147.61 94.33 -38.43 – 
333.66 
133.38 95.12 -54.23 – 
320.99 
147.73 97.14 -43.93 – 
339.39 
Education 67.17 43.57 -18.77 – 
153.1 
55 44.28 -32.34 – 
142.35 
51.9 44.37 -35.61 – 
139.42 
37.1 45.03 -51.74 – 
125.94 
ICV 33.06 45.05 -55.79 – 
121.92 
38.85 45.16 -50.22 – 
127.92 
35.8 45.24 -53.43 – 
125.03 




   -77.61 108.28 -291.17 – 
135.96 
-78.39 108.52 -292.44– 
135.67 




   -208.59 134.86 -474.57 – 
57.39 
-240.79 140.73 -518.38 –   
36.81 
-211.29 151.05 -509.29 – 
86.71 
RA       -38.89 50.4 -138.29 – 
60.51 
8.77 114.42 -216.97 – 
234.51 
CS       -72.39 54.26 -179.42 – 
34.64 
-74.22 114.23 -299.59 – 
151.14 
Group x Vision            
MCI x RA         -34.72 
 
135.74 -302.52 –  
233.07 
AD x RA         -120.79 162.79 -441.97 – 
200.4 
MCI x CS         -22.34 135.33 -289.35 – 
244.66 




.00 .01 .01 .00 
AIC  3140.38 3141.85 3143.95 3151 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Calcarine Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2976 88.8 2801 – 3152 
MCI 2899 60.6 2779 – 3018 
AD 2768 94.6 2581 – 2954 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 77.6 108 .72 .75 
SCD – AD 208.6 135 1.55 .27 
MCI – AD 131 112 1.17 .47 





Regression Models for the Thickness of the Right Calcarine Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .00 .01 -.02 – .02 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
Sex  -.01 .02 -.06 – .03  .01 .02 -.04– .05 .00 .02 -.04 – .04 .00 .02 -.04 – .05 
Education .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .02 .01 .01 -.01 – .03 
ICV -.00 .01 -.02 – .02 .00 .01 -.02 – .02 -.00 .01 -.02 – .02 .00 .01 -.02 – .02 
Group 
(MCI) 
   -.06* .02 -.11 – -.01 -.06* .02 -.1 – -.01 -.06* .03  -.12 – -.01 
Group 
(AD) 
   -.11*** .03 -.17 – -.05 -.11*** .03 -.17 – -.05 -.12*** .03 -.19 – -.05 
RA       -.02* .01 -.05 – -.00 -.04 .03 -.09 – .01 
CS       -.01 .01 -.04 – .01 -.02 .03 -.07 – .03 
Group x Vision            
MCI x RA         .01 .03 -.05 – .07 
AD x RA         .00 .04 -.07 – .07 
MCI x CS         .01 .03 -.05 – .07 
AD x CS         .04 .04 -.03 – .11 
Adjusted 
R2 
-.01 .05 .06 .05 
AIC  -206.31 -216.27 -217.11 -208.15 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Calcarine Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2 .02 1.96 – 2.04 
MCI 1.99 .01 1.96 – 2.01 
AD 1.93 .02 1.88 – 1.97 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .02 .68 .78 
SCD – AD .08 .03 2.59 .03 
MCI – AD .06 .03 2.46 .04 





Regression Models for the Volume of the Right Anterior Occipital Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -36.39 
* 
17.28 -70.47 – 
-2.3 
-31.94 17.67 -66.79 – 
2.91 
-24.45 18.27 -60.48 – 
11.59 
-23.38 18.79 -60.44 – 
13.69 
Sex  33.78 36.03 -37.28 – 
104.84 
40.58 37.57 -33.53 – 
114.69 
49.94 37.62 -24.25 – 
124.14 
46.63 39.01 -30.34 – 
123.59 
Education -10.2 17.32 -44.36 – 
23.96 
-13.13 17.64 -47.93 – 
21.66 
-11.23 17.55 -45.84 – 
23.38 
-11.58 18.08 -47.25 – 
24.09 
ICV 18.4 17.91 -16.92 – 
53.72 
20.25 17.99 -15.22 – 
55.73 
22.19 17.89 -13.1 – 
57.48 




   .16 43.13 -84.91 – 
85.23 
.11 42.92 -84.54 – 
84.77 




   -55.66 53.72 -161.61 – 
50.29 
-38.18 55.66 -147.96 –   
71.61 
-38.86 60.65 -158.53 – 
80.8 
RA       27.79 19.93 -11.52 – 
67.1 
39.22 45.95 -51.43 – 
129.86 
CS       44.65* 21.46 2.32 – 
86.97 
57.52 45.87 -32.98 – 
148.01 
Group x Vision            
MCI x RA         -14.44 
 
54.51 -121.98 –  
93.09 
AD x RA         -15.88 65.37 -144.85 – 
113.1 
MCI x CS         -6.3 54.34 -113.51 – 
100.92 




.02 .02 .03 -.00 
AIC  2771.38 2773.66 2772.89 2786.04 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Anterior Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 1005 35.4 935 – 1075 
MCI 1005 24.1 958 – 1053 
AD 950 37.7 875 – 1024 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -.16 43.1 -.00 1.00 
SCD – AD 55.66 53.7 1.04 .56 
MCI – AD 55.82 44.6 1.25 .43 





Regression Models for the Thickness of the Right Anterior Occipital Sulcus 
Variable 
Model 1 Model 2 Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .00 .01 -.02 – .03 .01 .01 -.02 – .03 .01 .01 -.02 – .03 .01 .01 -.01 – .04 
Sex  -.00 .02 -.05 – .05  .01 .03 -.04 – .06 .01 .03 -.05 – .06 .01 .03 -.05 – .06 
Education .01 .01 -.02 – .03 .00 .01 -.02 – .03 .01 .01 -.02 – .03 .01 .01 -.02 – .03 
ICV -.01 .01 -.04 – .01 -.01 .01 -.04 – .01 -.01 .01 -.04 – .01 -.01 .01 -.03 – .02 
Group 
(MCI) 
   -.03 .03 -.09 – .03 -.03 .03 -.08 – .03 -.03 .03  -.09 – .04 
Group 
(AD) 
   -.05 .04 -.12 – .02 -.04 .04 -.11 – .04 -.05 .04 -.13 – .03 
RA       -.01 .01 -.04 – .02 -.04 .03 -.1 – .03 
CS       .00 .01 -.02 – .03 -.01 .03 -.07 – .05 
Group x Vision            
MCI x RA         .03 .04 -.05 – .1 
AD x RA         .03 .04 -.06 – .12 
MCI x CS         .04 .04 -.04 – .11 
AD x CS         -.00 .04 -.09 – .09 
Adjusted 
R2 
-.01 -.01 -.02 -.03 
AIC  -142.72 -140.5 -137.75 -129.15 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Anterior Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.25 .02 2.21 – 2.3 
MCI 2.23 .02 2.19 – 2.26 
AD 2.21 .03 2.16 – 2.26 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .03 .03 .93 .62 
SCD – AD .05 .04 1.3 .4 
MCI – AD .02 .03 .66 .79 





Regression Models for the Volume of the Right Parieto-Occipital Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age -38.14 36.84 -110.8 – 
34.52 
-10.49 36.52 -82.52 – 
61.53 
-1.88 38.14 -77.11 – 
73.35 
-3.35 38.91 -80.11 – 
73.41 
Sex  96.32 76.81 -55.17 – 
247.8 
165.34* 77.65 12.19 – 
318.5 
166.32* 78.52 11.44 – 
321.21 
146.37 80.78 -13 – 
305.74 
Education 69.78 36.93 -3.05 – 
142.6 
45.74 36.45 -26.16 – 
117.64 
46.89 36.63 -25.36 – 
119.13 
50.8 37.44 -23.07 – 
124.67 
ICV 80.75* 38.18 5.45 – 
156.05 
92.19* 37.17 18.87 – 
165.51 
92.88* 37.35 19.22 – 
166.55 




   -153.35 89.13 -329.15 – 
22.46 
-149.42 89.59 -326.13 – 
27.3 




   -412.09*** 111.01 -631.04 – 
-193.13 




125.6 -647.48 – 
-151.88 
RA       -12.6 41.61 -94.67 – 
69.46 
106.2 95.14 -81.51 – 
293.91 
CS       25.63 44.8 -62.73 – 
113.99 
58.92 94.99 -128.48 – 
246.32 
Group x Vision           
MCI x RA         -186.25 
 
112.87 -408.93 – 
36.44 
AD x RA         -84.88 135.37 -351.96 – 
182.2 
MCI x CS         -61.11 112.54 -283.14 – 
160.92 




.04 .09 .09 .07 
AIC  3074.17 3064.02 3067.28 3077.21 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 




Pairwise Comparisons between Groups in Volume of the Right Parieto-Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 3123 73.1 2979 – 3267 
MCI 2969 49.9 2871 – 3068 
AD 2711 77.8 2557 – 2864 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 153 89.1 1.72 .2 
SCD – AD 412 111 3.71 .00 
MCI – AD 259 92.3 2.8 .02 





Regression Models for the Thickness of the Right Parieto-Occipital Sulcus 
Variable 
Model 1 Model 2** Model 3 Model 4 
B SE 95% CI B SE 95% CI B SE 95% CI B SE 95% CI 
Age .00 .01 -.02 – .02 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
Sex  -.01 .02 -.06 – .03  .01 .02 -.03 – .05 .01 .02 -.04 – .05 .01 .02 -.04 – .05 
Education .02 .01 -.00 – .04 .01 .01 -.01 – .03 .01 .01 -.01 – .03 .01 .01 -.01 – .03 
ICV -.01 .01 -.03 – .01 -.01 .01 -.03 – .01 -.01 .01 -.03 – .01 -.00 .01 -.03 – .02 
Group 
(MCI) 
   -.06* .03 -.11 – -.01 -.06* .03 -.11 – -.01 -.06* .03  -.11 – -.00 
Group 
(AD) 
   -.12*** .03 -.18 – -.06 -.11*** .03 -.18 – -.04 -.12** .04 -.19 – -.05 
RA       -.01 .01 -.03 – .02 -.00 .03 -.05 – .05 
CS       .01 .01 -.02 – .03 .01 .03 -.04 – .06 
Group x Vision            
MCI x RA         -.01 .03 -.07 – .05 
AD x RA         -.02 .04 -.1 – .06 
MCI x CS         -.00 .03 -.07 – .16 
AD x CS         .01 .04 -.07 – .08 
Adjusted 
R2 
.01 .07 .06 .04 
AIC  -189.68 -199.57 -196.35 -184.78 
Note. ** p < .01, * p <.05; RA = reading acuity, CS = contrast sensitivity; SE = standard error. Bolded model indicates best predictive model 





Pairwise Comparisons between Groups in Thickness of the Right Parieto-Occipital Sulcus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.2 .02 2.16 – 2.24 
MCI 2.14 .01 2.11 – 2.17 
AD 2.08 .02 2.04 – 2.13 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .06 .03 2.45 .04 
SCD – AD .12 .03 3.71 .00 
MCI – AD .06 .03 2.1 .09 






Pairwise Comparisons between Groups in Volume of the Left Precentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 5622 96.7 5431 – 5813 
MCI 5644 66 5514 – 5774 
AD 5405 103 5202 – 5608 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -22.4 118 -.19 .98 
SCD – AD 216.6 147 1.47 .31 
MCI – AD 239 122 1.96 .13 
Note. Results are averaged over the levels of sex. 
 
 
Table 75  
 
Pairwise Comparisons between Groups in Thickness of the Left Precentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.65 .03 2.59 – 2.7 
MCI 2.65 .02 2.61 – 2.69 
AD 2.63 .03 2.58 – 2.69 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -.00 .03 -.13 .99 
SCD – AD .01 .04 .32 .95 
MCI – AD .02 .03 .51 .87 





Pairwise Comparisons between Groups in Volume of the Left Postcentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 3749 85.9 3579 – 3918 
MCI 3776 58.6 3660 – 3892 
AD 3710 91.5 3530 – 3890 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -27.4 105 -.26 .96 
SCD – AD 38.6 130 .3 .95 
MCI – AD 66 108 .61 .82 





Pairwise Comparisons between Groups in Thickness of the Left Postcentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.11 .02 2.06 – 2.15 
MCI 2.14 .02 2.11 – 2.17 
AD 2.11 .02 2.06 – 2.15 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -.03 .03 -1.09 .52 
SCD – AD .00 .03 .01 .99 
MCI – AD .03 .03 1.07 .53 





Pairwise Comparisons between Groups in Volume of the Right Precentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 5632 99.3 5435 – 5828 
MCI 5606 67.7 5472 – 5740 
AD 5407 105.7 5199 – 5616 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI 25.9 121 .21 .97 
SCD – AD 224.6 151 1.49 .3 
MCI – AD 198.8 125 1.59 .25 





Pairwise Comparisons between Groups in Thickness of the Right Precentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.66 .03 2.6 – 2.72 
MCI 2.63 .02 2.6 – 2.67 
AD 2.63 .03 2.57 – 2.69 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .04 .64 .8 
SCD – AD .03 .04 .68 .77 
MCI – AD .01 .04 .21 .98 






Pairwise Comparisons between Groups in Volume of the Right Postcentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 3444 74.3 3298 – 3591 
MCI 3470 50.7 3370 – 3570 
AD 3304 79.2 3148 – 3460 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI -26.1 90.6 -.29 .96 
SCD – AD 140.2 112.9 1.24 .43 
MCI – AD 166.4 93.8 1.77 .18 





Pairwise Comparisons between Groups in Thickness of the Right Postcentral Gyrus 
Group Estimated Marginal Mean SE 95% CI 
SCD 2.15 .02 2.1 – 2.2 
MCI 2.13 .02 2.1 – 2.16 
AD 2.11 .03 2.06 – 2.16 
Group Contrast Contrast Estimate (B) SE T p-value 
SCD – MCI .02 .03 .65 .79 
SCD – AD .04 .04 1.24 .43 
MCI – AD .03 .03 .86 .67 
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Figure 2  




Note. Reading acuity was measured using the MNRead Acuity Charts. * indicates a significant 













Figure 3  




Note. Contrast sensitivity was measured using the MARS Contrast Sensitivity Test. * indicates a 
significant difference between groups (p < .01). 
 
